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Background and Aim 
Dental caries is one of the most prevalent infectious diseases worldwide, affecting the 
majority of children and adults. It represents an opportunistic infection of dental hard tissues 
by oral or transient microorganisms1. With the spread of the caries towards the dentin the 
pulp becomes inflamed, i.e. it develops a pulpitis2. If the caries lesion progresses further, 
microorganisms will gain direct access to the pulp space eventually. This results in local 
micro-abscess formation, digestion of the pulp tissue by proteolytic enzymes, and finally 
necrosis of the whole dental pulp3. As the infection spreads from the coronal to the apical 
aspects of the root canal system, the periapical tissues get involved. Microbial by-products 
and endotoxins cause inflammation and resorption of the periapical bone. Collectively, all the 
inflammatory stages of the periapex that are caused by the infection of the dental pulp space 
are called apical periodontits4. Hence, pulpitis and apical periodontitis are different, 
dynamically evolving inflammatory stages of endodontic microbial infection. 
Medical diagnostic tests are performed to identify the presence of a specific disease 
and to determine its treatment. Histologic processing represents the gold standard for 
detecting pulpal and periapical inflammation5. For obvious reasons this is not applicable for 
teeth that are to be preserved. Therefore, current endodontic diagnostic procedures that aim 
to assess the stages of pulpal and periapical inflammation involve case history, as well as 
clinical and radiographic examination. The clinical examination includes different procedures 
such as inspection, pulp sensitivity to thermal or electric stimuli, and the assessment of pain 
on palpation or percussion. Based on these findings pulpal (normal, reversibly inflamed, 
irreversibly inflamed, or necrotic pulp) and periapical (normal apical tissues, apical 
periodontits, apical abscess, or condensing osteitis) diagnoses can be made6.  
The clinical procedures for pulpal diagnostics have not changed much in the last 
century7. However, a poor correlation between those tests and the actual histopathological 
state of the pulp has been revealed5, 8. A recently performed systematic review concluded 
that there is insufficient evidence for the accuracy of clinical endodontic tests in detecting the 
inflammatory state of the pulp, even if these tests are combined9. The authors concluded that 
current endodontic diagnostic procedures need to be improved, and that biological markers 
for pulpal inflammation warrant further investigation.  
Periapical diagnostics essentially comprises the interpretation of periapical 
radiographs. However, the limitations of two-dimensional imaging in depicting periapical 
bone changes are well known. Apical periodontitis in cancellous bone, for example, 
radiographically can be covered by thick cortical bone. Consequently, apical inflammation 
can be missed even though extensive disease is present10, 11. Moreover, the apparent 
healing of apical periodontits on periapical radiographs can take up to 4 years, or even 
longer12. Theoretically these shortcomings may be overcome by 3-D imagining techniques 
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such as cone beam computed tomography (CBCT)13. However, because of the 
comparatively high radiation dose to oral tissues, CBCT is currently not recommended for 
standard periapical diagnostics, or for monitoring periapical health14. 
Since the current clinical endodontic diagnostic procedures are not necessarily 
reliable, the thus-resulting pulpal and periapical diagnoses are relatively poor. On the one 
hand, this can lead to over-treatment (i.e. pulpectomy in cases that could be kept vital), 
whereas on the other, treatment failures may remain undetected. Keeping in mind that the 
underlying cause for pulpal and periapical infections are microorganisms that cause 
inflammation by the host, endodontic diagnostics could also focus on either the extent of the 
microbial infection, or the inflammatory reaction of host tissues. Therefore, the aim of this 
cumulative synthesis of experiments is to refine current endodontic diagnostics and to 
investigate alternative diagnostic approaches, which target the presence of microorganisms, 
or the host response.  
 
METHODS 
Firstly, a prospective, observational study was performed enrolling emergency patients that 
visited the University of Zurich, Center of Dental Medicine because of acute pain caused by 
an endodontic infection. The patients were comprehensively examined and asked 11 specific 
questions from a checklist with a possible diagnostic discerning value between two forms of 
endodontic infections: acute apical periodontitis and acute (irreversible) pulpitis. In addition, 
the pain levels were assessed using a numerical rating scale (NRS-11). Subsequently, a 
decision tree was constructed based on recursive partitioning to identify a hierarchy in the 
symptoms differentiating between the two conditions. 
Secondly, the currently available scientific literature was systematically analyzed in 
order to identify potential biological markers that may be used to target pulpal inflammation. 
An extensive electronic literature search was performed to look for studies that differentiated 
between a healthy and an irreversibly inflamed pulp in permanent human teeth by analyzing 
interstitial/ dentinal fluid, gingival crevicular fluid, pulpal tissue, periapical fluid or apical blood 
for the presence of a biological marker. The last date entered was February 19, 2015 and no 
language restrictions were imposed. The quantitative data was collected from all studies 
included to the review and the quality of theses studies was assessed. One promising 
substrate for molecular analysis was found to be dentinal fluid. However, the vehicle (a 
polyvinylidene fluoride membrane, PVDF) used for collecting the dentinal fluid in a pilot study 
was not perfectly suitable for this purpose15. 
Therefore, in a third study performed, alternative vehicles were compared to a PVDF 
counterpart for their ability to absorb water and release protein. In a subsequent comparative 
clinical trial, the cellulose vehicle with the most favorable outcome during pre-assessment 
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was compared to PVDF regarding the levels of matrix metalloproteinase-2 (MMP-2) that 
could be collected from dentinal fluid of healthy human teeth during filling replacement. The 
MMP-2 levels were determined by enzyme-linked immunosorbent assay (ELISA). Data from 
the laboratory experiments were compared between materials using appropriate parametric 
tests. 
A further (fourth) attempt aimed at investigating the expression of host-factors that 
may serve as biological markers for periapical inflammation kinetics during the development 
of apical periodontitis. In a clinical trial, symptomatic teeth without the presence of apical 
periodontitis (diagnosed with irreversible pulpitis) were compared to teeth with symptomatic 
apical periodontitis. Cellulose paper points were used to collect periapical tissue fluid during 
root canal treatment of these teeth. The samples were evaluated for the presence of 
interleukin-8 (IL-8), receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) 
using ELISA. Target protein levels per case were calibrated against the corresponding total 
protein content and statistically compared.  
A fifth study and first of its kind focused on detecting key microbial taxa 
(Synergistetes, Actinomyces, and Fusobacteria) directly in periapical tissue fluid samples as 
described above in three defined stages of periapical disease:  irreversible pulpitis but 
normal apical tissues, pulp necrotic teeth with apical periodontitis, or apical periodontitis 
associated with a root-filled tooth. Samples were investigated using FISH staining and 
epifluorescence microscopy. A semi-quantitative evaluation of the stained bacterial taxa was 
performed. 
 
FINDINGS 
The most accurate indicator for discerning between acute forms of pulpitis and apical 
periodontitis was absence of pain to cold stimuli in the latter condition. In eighty percent of 
the teeth with acute apical periodontitis patients did not report pain on cold. In teeth that did 
have a history of pain triggered by cold stimuli, the decision tree still correctly identified acute 
apical periodontitis in 72 % of the teeth that felt too high and had hurt for less than one week. 
The median pain levels reported by the patients diagnosed with acute forms of pulpitis and 
apical periodontitis did not show statistical differences (P < 0.05; median NRS-11 = 8, for 
both diagnoses). Consequently, pain levels are not useful to diagnostically differentiate 
between those conditions  
From the 851 articles screened for the systematic review, 57 met the inclusion criteria 
and analyzed a potential biomarker to differentiate between a healthy and an irreversibly 
inflamed pulp. Most of the included studies evaluated pulp tissue (50/57), whereas merely 
12% (7/57) analyzed other substrates such as pulpal blood (N = 2), or dentinal fluid (N = 1). 
From the 89 potential biological markers assessed in pulp tissue and the 16 evaluated in 
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other substrates, 71.9% and 75% respectively, revealed statistical significant differences 
between an irreversible inflamed and a healthy pulp.  
A large-pore cellulose membrane was shown to be ideal for collecting biological 
markers from dentinal fluid. Compared to a standard PVDF membrane, the cellulose 
membrane absorbed significantly more water and released proteins as well as the PVDF 
membrane (P < 0.05). Matrix metalloproteinase-2 could be collected at an ELISA quantifiable 
level from the dentine of healthy teeth using the cellulose membrane in 9 of 13 cases, 
compared to merely 1 of 13 with the PVDF membrane  (P < 0.05). Consequently, using 
large-pore cellulose should improve the analysis of low-available body fluids such as dentinal 
fluid, or periapical tissue fluid.  
The periapical tissue fluid, which was collected from symptomatic teeth without the 
presence of apical periodontitis (irreversible pulpitis) and teeth with symptomatic apical 
periodontitis employing cellulose paper points, revealed a significantly (P < 0.05) negative 
correlation between RANKL and IL-8. High levels of RANKL, a molecular marker stimulating 
osteoclast activation and bone resorption, were present during initial periapical lesion 
development (i.e. during irreversible pulpitis). A high level of IL-8, a cytokine strongly 
associated with neutrophil recruitment and activation (i.e. with inflammation), was 
diagnostically indicative for already established periapical lesions. This suggests that in the 
development of apical periodontitis molecular activation of bone resorption takes place 
before inflammatory cell recruitment. However, OPG was under the detection limit in most 
samples regardless of their diagnosis. Apparently OPG does not bear much of diagnostic 
information for monitoring the periapical inflammatory reaction.  
For the first time it was shown, that FISH can be used to detect individual taxa and 
even biofilm fragments in  tissue fluid samples of teeth with different clinical conditions. It was 
shown that Actinomyces were significantly more prevalent in root-filled teeth with apical 
periodontitis (10/21) compared to counterparts with primary apical periodontitis (4/33) or 
pulpitis (0/27). 
 
DISCUSSION 
Collectively, the studies presented here address the diagnostics of endodontic 
disease. The current clinical diagnostic procedures for pulpal and periapical inflammation 
and infection indubitably have their shortcomings5, 8. However, it must be noted that the 
reliability of these tests greatly depends on the condition to be diagnosed. Their main 
weakness lies in discriminating a healthy condition from the beginning of the disease. In 
contrast, definite biological states can be diagnosed with good reliability. For example, it is 
possible to identify an irreversibly inflamed pulp in an acute painful tooth with high 
sensitivity16. And it could be shown that a tooth that does not react on cold testing and shows 
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a periapical translucency radiographically almost invariably contains a necrotic pulp3. 
Consequently, the diagnoses that were used here for the clinical trials can be regarded as 
sound. Rigorously combining and analyzing all potentially relevant information together in a 
checklist approach enabled constructing a hierarchy in differentiating symptoms for different 
conditions. Such information bears diagnostic value for performing cross-sectional studies 
and to diagnose and advice patients during out-of hours calls. However, unfortunately the 
current clinical diagnostic tests do not address all relevant questions to be asked. In the 
context of vital pulp treatment for example, the challenge lies in determining how far the 
inflammation of the pulp has actually progressed before it reaches an irreversibly inflamed 
condition17. The systematic review showed that there is a different expression of 
immunological factors in a healthy and an inflamed pulp on the molecular level. These 
markers may be used to determine (and diagnose) pulpal inflammation. However, the review 
also revealed that there is currently not much research available specifically designed for that 
purpose. Conversely, a group of experts in the field have demanded methods that target the 
extent of the microbial infection, or the inflammatory reaction of the host tissue9. Dentinal 
fluid analysis, as one example, could be applied to address the clinically relevant question of 
whether or not a pulp has a chance to survive a treatment such as direct capping, or an 
abutment preparation for placement of a crown18, 19. Studies, that are specifically designed to 
improve methodological issues, such as the sampling vehicle, build the foundation for their 
potential clinical application. The same applies for studies involving periapical tissue fluid 
analyzes. There are clearly advantages analyzing periapical tissue fluid for microbial 
infection and inflammatory host-factors. For example, a distinct periapical translucency on a 
radiograph represents a quantifiable endpoint for the presence of inflammation, and the 
pathology is accessible in an enclosed, circumscribed area20, 21. Here, it was possible to 
identify different endodontic key taxa in the periapical tissue fluid of teeth that differed with 
respect to their root canal content (root-filled vs. necrotic), but periapically showed the exact 
same diagnoses (chronic apical periodontitis) based on conventional diagnostic methods. 
Regarding the analysis of periapical tissue fluid for immunological host-factors to monitor 
periapical health, it would be of great interest to know as early as possible whether an apical 
periodontitis begins to heal after initiation of a root canal treatment. This was shown to be 
measurable by analyzing molecular markers in periapcial tissue fluid22. Knowing the 
dynamics, when molecular biological markers are expressed during the development of 
apical periodontitis (as investigated here), sets the framework for such applications.  
Collectively, the experiments performed here point into the direction that such 
diagnostic methods based on molecular tests are applicable under well-controlled conditions 
and can be developed. However, many possible impasses have yet to be overcome before a 
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clinical application can be considered. It appears to be worth performing further research into 
this direction. 
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RESEARCH ARTICLE Open Access
Pain levels and typical symptoms of acute
endodontic infections: a prospective,
observational study
Dan-Krister Rechenberg1*, Ulrike Held2, Jakob M. Burgstaller2, Gabriel Bosch1 and Thomas Attin1
Abstract
Background: This study aimed to identify key symptoms that could be associated with the diagnosis of acute
forms of symptomatic apical periodontitis (SAP) and symptomatic irreversible pulpitis (SIP), and to identify a
diagnostic algorithm based on these symptoms.
Methods: In this prospective, observational study 173 emergency patients diagnosed with acute pain of
endodontic origin and no swelling or fistula were included. Patients were asked 11 specific questions from a
checklist with a possible discerning value between acute SAP and acute SIP. Pain levels were recorded using the
numeric rating scale (NRS-11). Subsequently, the painful tooth was diagnosed. Logistic regression was used to
evaluate the checklist regarding its differentiation between SAP (N = 103) and SIP (N = 70). Moreover, a decision tree
was constructed based on recursive partitioning to identify a hierarchy in differentiating symptoms.
Results: With identical median NRS-11 scores of 8, the teeth diagnosed with acute SAP and SIP were severely
painful. The decision tree analysis resulted in a tree with splits according to pain on cold, perceived tooth extrusion,
and pain duration. The overall sensitivity of the tree to detect SAP based on key symptoms was 95 %, its specificity
was 31 %.
Conclusions: The best indicator for SAP was a reported absence of pain to cold stimuli. In teeth that did have a
history of pain triggered by cold stimuli, the decision tree correctly identified SAP in 72 % of the teeth that felt too
high and had hurt for less than one week.
Keywords: Pain, Root canal, Symptom, Diagnostic
Background
Odontalgia is the main cause of oro-facial pain [1].
Acute dental pain is mostly attributed to microbial infec-
tion of the dentin being in close proximity to the pulp,
the pulp space and finally the periapical tissues [2, 3].
The pulp, the periodontal ligament, and the periapical
tissues form natural barriers, which help the host or-
chestrate a defense against invading opportunistic patho-
gens [4]. When these barriers are invaded with
pathogens nociceptors are activated due to inflammation
and tissue breakdown [5]. Three symptomatic clinical
conditions deriving from endodontically involved teeth
have been identified: symptomatic irreversible pulpitis
(SIP), symptomatic apical periodontitis (SAP) and acute
apical abscess (AAA) [6]. Even though these can be ex-
tremely painful [2, 7], they do not need to be [8, 9]. Un-
fortunately, the current diagnostic nomenclature of the
American Association of Endodontists (AAE; [6]) does
not differentiate between teeth that cause significant
enough pain to require the patient to seek emergency
care from those, which merely show an increased reac-
tion to diagnostic tests [10].
The socioeconomic importance of dental pain has long
been recognized [11]. It has thus been attempted to de-
velop specific dental pain questionnaires for epidemio-
logic studies [12]. These questionnaires appear to have
good predictive values to differentiate between groups of
conditions, such as those that are caused by endodontic
* Correspondence: dan.rechenberg@zzm.uzh.ch
1Department of Preventive Dentistry, Periodontology and Cariology, Center
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infections and those that are not. However, they do not
differentiate the main causes of severe dental pain eman-
ating from endodontic origin. There have been other ap-
proaches, which were more specific. However, these
frequently mixed symptoms reported by the patients
with clinical observations by the investigators [13, 14].
The significance of establishing the correct diagnosis of
endodontic infections should not be under-estimated
[15]. If endodontic infections are not treated appropri-
ately, life-threatening conditions can evolve [16]. Due to
the obvious clinical symptom of edema (swelling) associ-
ated with the diagnosis of AAA, this diagnosis poses no
challenge. In contrast, clear-cut symptoms have not been
identified to differentiate between SAP and SIP. While
SIP is merely painful, SAP is the beginning of the spread
of infection with a possibility of untoward systemic con-
sequences [16]. Abscess formation, where bacteria are
invariably present in the periodical tissues, marks one
possible endpoint of this infection process [17]. Depend-
ing on the severity of the infection and the location of
the tooth, SAP can even lead to the death of the patient
if not treated appropriately [18]. Furthermore, the emer-
gency treatment for SIP and SAP differs [15]. With SIP,
simply removing the coronal pulp is sufficient for relief
[19], while with SAP the disinfection of the entire root
canal system is needed. It would thus be helpful to fur-
ther investigate symptoms including pain levels and pain
duration that can be specifically related to the acute
forms of SIP and SAP.
In this prospective, observational study, adult patients
seeking emergency care in a dental hospital because of
inflammatory conditions caused by infection of the pulp
space were assessed. The aim of the study was to identify
key symptoms that could be associated with either SIP
or SAP, and to identify a diagnostic algorithm based on
these symptoms. Symptoms were related to clinical
signs/findings.
Methods
Cohort identification and inclusion criteria
All patients attending the dental emergency unit at our
institution from opening at 07:30 am to 10 am were
considered. It was aimed to include all adult (18 years or
older) patients presenting with acute pain from a per-
manent tooth caused by an endodontic infection. The
emergency unit consisted of physicians and dentists
from all dental specialties. After a short first examination
by an oral surgeon, patients diagnosed with pericoronitis
or temporomandibular joint pain were referred to the
Oral Surgery department. All other patients were re-
ferred to the Department of Preventive Dentistry, Peri-
odontology and Cariology for further examination.
Patients who did not present with spontaneous pain, but
merely reported slight discomfort to stimuli indicative of
reversible pulpitis were not considered as’acute’. These
patients did not enter the study. The remaining patients
presenting with acute pain from a permanent tooth were
asked to participate in the study (Fig. 1). Written in-
formed consent was obtained from all patients. The
current study protocol was approved by the local ethics
committee (KEK-ZH-Nr. 2012-0450) and was conducted
in accordance with the Declaration of the World Med-
ical Association. Moreover, it was confirmed that this in-
vestigation conformed to STROBE guidelines for
observational studies. Patients were excluded from the
study if they: (i) were not able to clearly communicate in
German or English language, (ii) refused to participate,
(iii) refused to be, or could not be (pregnancy) diagnosed
radiographically, (iv) were on immunosuppressant or
long-term anti-inflammatory medication, or took antibi-
otics during the last 3 weeks, (v) had already initiated
treatment of their pain-causing tooth/condition, (vi)
could not be diagnosed clearly, (vii) had a condition that
was not due to an endodontic infection, or (viii) were di-
agnosed with an acute apical abscess.
Checklist for key symptoms and pain assessment
Participants who fulfilled the inclusion criteria were
interviewed using a checklist with 11 dichotomous
questions with a possible discerning value between
SIP and SAP (Table 1). This checklist listed symp-
toms that have been reported in the endodontic lit-
erature [20]. It also contained an assessment of pain
intensity and duration. The checklist was originally
written in German and translated to English for
international patients. It was piloted by the authors
of this communication and later filled in by either
one of two investigators (DKR and GB). Patients
were guided through these questions by one of these
two investigators. Patients who could not communi-
cate clearly were excluded. In addition, the pain in-
tensity of the presenting condition was assessed
using the numeric rating scale (NRS-11; [21]). The
examiner asked the patient to quantify his/her max-
imum pain intensity within the last 24 h on a scale
from 0 to 10. The following anchors were used to
describe the rating scale:’0’ = no pain/pain free and
‘10’ = worst pain imaginable.
Diagnosis
The clinical evaluation included cold testing with carbon
dioxide snow, assessment of tenderness to percussion,
tooth mobility, and periodontal probing depths. Moreover,
the soft tissues were checked for tenderness to palpation,
signs of erythema, and presence of a sinus tract or swell-
ing. The findings were compared to a healthy, contralat-
eral tooth that served as a control. Radiographic
examination was performed using single-tooth
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radiographs (Digora, Soredex, Tuusula, Finland). The dif-
ferent inflammatory endodontic conditions (SIP, SAP, or
AAA) were established according to the recommended
diagnostic terminology of the Consensus Conference of
the AAE [6]. In a deviation from that nomenclature, how-
ever, each tooth was assigned only one main diagnosis
(Table 2). The examiner noted this diagnosis, together
with relevant data (date, gender, age, analgesics taken in
the past 24 h) in an anonymized data sheet.
Statistics and data evaluation
Descriptive statistics included counts and percentages
for the questions on pain history. Categorical data was
compared between groups using the Chi-squared test.
NRS-11 pain levels, which are non-interval ratings, were
compared between groups using Mann–Whitney U test.
The alpha-type error was set at 5 %. To assess the diag-
nostic value of the 11 symptoms (other than pain) be-
tween SAP and SIP, a multiple logistic regression model
was fitted to the outcome variable SAP. All of the vari-
ables of the checklist were included in order to obtain a
predicted probability for SAP for each individual patient.
Because some teeth were bridge abutments and the
question did thus not make sense, the variable “Tooth
feels too high” had 11 missing values. These were multi-
ply imputed with 5 replications. Results of the logistic
regression are based on the pooled estimates of the 5
imputed data sets. The area under the receiver operating
characteristic (AUC) curve was used to evaluate the dis-
criminative ability of the regression model.
In an alternative approach recursive partitioning was
used to construct a decision tree. The focus of the tree
was to facilitate the diagnostic decision between SAP
and SIP. All variables of the checklist were included in
the tree model. All analyses were conducted using R
statistical software [22].
Results
Study population and teeth
From January 2013 over a period of 15 month (64 weeks)
368 adult patients attended the dental emergency unit at
our institution with severe pain on a permanent tooth.
One hundred and forty-seven were not eligible to enter
the study because they did not meet the criteria for in-
clusion (Fig. 1). From the 221 patients with acute pain of
endodontic origin, 70 were diagnosed with SIP, 103 with
SAP and 48 with AAA. The 48 individuals diagnosed
with AAA were also excluded from analysis (Fig. 1). Of
Fig. 1 Flow chart depicting the decisions why patients were excluded from the study. All emergency patients presenting with severe pain
originating from a single endodontically involved tooth in the course of 64 weeks were initially considered. Teeth diagnosed with an acute apical
abscess were then excluded. SIP symptomatic irreversible pulpitis, SAP symptomatic apical periodontitis.
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the remaining 173 patients diagnosed with either SIP or
SAP, the ratio between females to males was 70/103.
The average patient age was 40 years and ranged be-
tween 18 and 78 years. The ratio between mandibular
and maxillary teeth was 107/66. One hundred and thirty
of the teeth were molars, 33 premolars and 10 anterior
teeth. One hundred and forty-seven of the teeth were
multi-rooted, and the remaining 26 were single-rooted.
Eleven of the 103 teeth diagnosed with SAP were root-
filled. There were no statistical differences regarding
tooth types between SIP and SAP in the current cohort
(P > 0.05).
Pain levels
Pain levels were statistically similar (P > 0.05) for both
conditions under investigation. Median NRS-11 rat-
ings were 8 for both SAP and SIP, with similar inter-
quartile ranges: 2 for SAP, 1 for SIP. There was also
no difference (P > 0.05) in pain levels between male
and female patients. Eighty-one percent (81 %) of the
patients used analgesics within the last 24 h before
seeking emergency treatment. There was no statistical
difference between the two conditions under investi-
gation in this regard either.
Key symptoms
Assessment of the checklist revealed that large differ-
ences in the symptomology of SAP and SIP were found
for pain duration, pain on cold, and the feeling that the
tooth was too high (Table 3). The prediction model,
based on the multiple imputed data set, is summarized
in Table 4. Furthermore, the estimated odds ratios and
95 % confidence intervals (CI) are displayed. The dis-
criminative ability of the prediction model resulted in an
AUC of 0.796 (95 % CI: 0.728–0.864). The decision tree
analysis (Fig. 2) resulted in a tree with splits according
to pain on cold, awareness of the tooth feeling too high,
and pain duration. The first indicator for SAP was a re-
ported absence of pain to cold stimuli. In teeth that did
have a history of pain triggered by cold stimuli, the deci-
sion tree correctly identified SAP in 72 % of the teeth
that felt too high and had hurt for less than one week.
The overall sensitivity of the tree was 95 % and the spe-
cificity was 31 %. The positive predictive value was 67 %.
Discussion
The current study related symptoms to clinical findings.
From an immediate treatment planning perspective, SAP
is the more critical condition, and its diagnosis should
not be missed [16]. It was confirmed that the reported
presence or absence of pain to cold stimuli was a first
differentiator between the clinical diagnoses of SAP and
SIP. Moreover, decision analysis identified additional
symptoms associated with a diagnosis of SAP also in
teeth with a history of pain to cold stimuli. If these felt
too high and had hurt for less than one week, the
Table 2 Clinical findings used in the current study to
differentiate between SIP and SAP
Criterion SIP SAP
Sensitivity to carbon dioxide snow + -
Radiographically widened ligament space +/- +
Periapical radiolucency - +/-
Swelling or sinus tract - -
SIP symptomatic irreversible pulpitis, SAP symptomatic apical periodontitis, +
positive response or sign clearly present, +/- mixed response or not present in
all cases, - negative response or clearly absent
Note: sensitivity to percussion was not included, as almost all of the acutely
painful teeth in this study responded positive to percussion
Table 3 Descriptive statistics: counts of symptoms in patients
diagnosed with SIP (N = 70) and SAP (N = 103)
Question SIP % SAP %
Sleep disturbed 56 80.0 % 87 84.5 %
Pain has decreased 11 15.7 % 12 11.7 %
Pain less 1 week 32 45.7 % 72 69.9 %
Constant pain 25 35.7 % 51 49.5 %
Radiating pain 25 35.7 % 26 25.2 %
Sharp pain 38 54.3 % 37 35.9 %
Pain on chewing 49 70.0 % 89 86.4 %
Pain on hot 28 40.0 % 29 28.2 %
Pain on cold 53 75.7 % 37 35.9 %
Cold lessens pain 5 7.1 % 18 17.5 %
Tooth feels higha 20 28.6 % 50 48.5 %
SIP symptomatic irreversible pulpitis, SAP symptomatic apical periodontitis
aThis variable had 11 missing values (teeth were bridge abutments)
Table 1 History checklist for dental emergency patients asking
for symptoms to possibly discern between SIP and SAP
# Question Answer options
1 Has the pain interfered with sleep? y/n
2 Has the pain ever been stronger than during the
last 24 h?
y/n
3 Did the pain start less than 1 week ago? y/n
4 Has the pain been sporadic or constant? sporadic/
constant
5 Has the pain been localized or radiating? localized/
radiating
6 How was the main quality of the pain? dull/sharp
7 Has chewing increased the pain? y/n
8 Have warm drinks/food increased the pain? y/n
9 Has cold increased the pain? y/n
10 Has cold decreased the pain? y/n
11 Does the affected tooth feel too high? y/n
SIP symptomatic irreversible pulpitis, SAP symptomatic apical periodontitis
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probability that SAP was diagnosed was still 72 %. A set
of questions was thus identified that should be helpful in
clinics and for cross-sectional studies to discern between
SAP and SIP.
The current study is limited by the fact that data were
generated in one single city. The relative frequency of
the conditions under investigation is influenced by
demographics, the local health care system and socio-
economic factors [23]. It would appear that in older
studies, SIP was more frequent than SAP [24], while
newer investigations including the current work found
the opposite [3]. This could be due to the fact that
caries, the main cause for symptomatic pulpitis [9,
25], has steadily declined in industrialized countries
[26]. Acute forms of apical periodontitis including ab-
scess formation, on the other hand, can occur as late
complications in crowned teeth and/or root-filled
counterparts [27].
While current pulp tests and two-dimensional radi-
ology are insufficient to determine the exact histo-
logical condition of asymptomatic teeth [28–30], the
methods that were used in the present study to dif-
ferentiate between the two acute conditions under in-
vestigation can be regarded as sound. The teeth
diagnosed with SIP mostly showed a delayed, yet al-
ways more pronounced reaction to the cold test com-
pared to healthy counterparts. It has been shown that
painful teeth responding with an delayed, but in-
creased and lingering response to the cold test invari-
ably contain a vital pulp or at least vital aspects of
the pulp in the apical root canal [25, 28]. In multi-
rooted teeth some roots may still contain vital tissue
that responds to thermal tests, while in other roots
the tissue can be partially necrotic [31]. These vital
aspects of the pulp inhibit bacterial infection [32].
Consequently, it is fair to state that acutely painful
teeth with positive response to cold test differ from
counterparts that test negatively in regard to the level
of infection. An intra-operative diagnosis upon enter-
ing the pulp space was not performed to differentiate
between SIP and SAP.
Table 4 Results of the prediction model for SAP
Odds ratio 95 % CI
Sleep disturbed 1.0 0.4–2.6
Pain has decreased 0.9 0.3–2.8
Pain less 1 week 2.1 1–4.4
Constant pain 1.6 0.8–3.4
Radiating pain 0.6 0.3–1.5
Sharp pain 0.5 0.2–1
Pain on chewing 2.5 1–6.3
Pain on hot 0.8 0.4–1.6
Pain on cold 0.2 0.1–0.5
Cold lessens pain 0.8 0.2–2.9
Tooth feels high 1.9 0.9–4.3
SAP symptomatic apical periodontitis, CI confidence Interval
Fig. 2 Decision tree to identify symptomatic apical periodontitis (SAP) based on recursive partitioning. SAP is the condition that can have
systemic consequences. Green arrows indicate a set of symptoms that lead to a likely diagnosis of SAP in teeth with a history of pain to
cold stimuli
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It is known that the intake of analgesics can affect
endodontic diagnosis. The pain perception itself can de-
crease, or the response to clinical test like tooth percus-
sion can be reduced [33]. However, the teeth under
investigation were severely painful. Although 81 % (N =
140) of the 173 patients included to this study had con-
sumed analgesics within the past 24 h before seeking
emergency treatment, 79 % (N = 136) of them reported
severe pain at levels between 7 and 10 on a NRS-11
scale [21]. Moreover, almost all teeth (92 %; N = 159)
featured a painful response to percussion. In contrast
the influence of analgesics on pulpal sensitivity test has
shown to be negligible [34]. Consequently, the influence
of analgesics on the diagnostic procedures performed
here is expected to be low. It needs to be acknowledged
that SIP and SAP are clinically defined separate diagnos-
tic entities based on a set of criteria defined by inter-
national consensus (and as such reported in textbooks
and major journal articles; [6]). SIP, SAP, and later AAA
are biological, dynamically evolving stages of the same
underlying bacterial infection. The transition from pulpi-
tis or chronic apical periodontitis to acute apical peri-
odontitis is clinically important, because it marks the
point when a spread of the infection from the pulp space
to the periapical tissues is about to occur [4]. However,
the transitions between these conditions are rarely clear-
cut [32]. Furthermore, transitions from one stage to the
next can be fast. This is reflected in the current data in
that 35.9 % of the patients diagnosed with acute SAP re-
ported a history of sensitivity to cold (Table 3). Almost
half of SAP teeth did not show clear apical radiolu-
cencies typical for chronic apical periodontitis (Table 2).
This can also be taken as an indicator that the inflam-
matory conditions in the periapical tissues developed
more rapidly than any radiologically discernible bone
changes occurred. This is in line with observations pub-
lished by other authors [10]. Some recent research sug-
gests that bone changes do occur early in the disease
process, when the pulp is still vital [35]. These changes,
however, are not necessarily detected on single-tooth ra-
diographs [36]. Cone beam computed tomography
(CBCT) was shown to be more sensitive in detecting ap-
ical disease [36]. The observation on the dynamics of
periapical bone changes made here warrants further in-
vestigation and verification using CBCT.
Earlier authors concur with the present results in that
pain to cold stimuli [28] and the feeling that the affected
tooth is too high [13] can help to differentiate between
SIP and SAP. However, it has to be cautioned that these
authors did not use the current nomenclature of the dis-
eases under investigation, and thus direct comparisons
are limited. The current finding that sensitivity to cold is
the main indicator for an inflamed vital pulp corre-
sponds to the observations made in the only study on
this topic in humans with induced pulpal inflammation
[37]. Consequentially, this should further the support of
cold testing e.g., carbon dioxide snow being the main
clinical test, in conjunction with radiographic images, to
diagnose SIP [25]. The patients diagnosed with SAP re-
ported significantly more often the perception that the
pain-causing tooth felt too high compared to patients di-
agnosed with SIP. This observation may be explained by
the spread of the inflammation to the periapical liga-
ment. The accumulation of inflammatory exudate may
extrude the affected tooth, thus rendering it tender to
occlusion [15]. Other common clinical tests were per-
formed in this study, but these were of little value in dif-
ferentiating between the acute forms of the conditions
under investigation. As an example, 159 (92 %) of the
173 teeth in this study were positive to percussion, with
no difference between the two conditions. This is in line
with published reports: the percussion test has little to
no diagnostic value [28, 38]. This is especially the case
with painful teeth [39]. Nevertheless, the test is used in
the current AAE nomenclature [6]. In accordance with
the AAE terminology each tooth that is sensitive to per-
cussion has a periapical diagnosis of “symptomatic apical
periodontitis [10, 40]. In the current report, however, the
comprehensive diagnosis of the acute forms of SAP be-
fore abscess formation versus SIP was based on the ther-
mal responsiveness of the pulp (Table 2).
Numerical rating scales have been validated, and are
commonly used for the assessment of pain intensities [7,
41]. The NRS-11 came to use here because of the inter-
view character of this study. In contrast to a visual
analogue scale, which is also commonly used in studies
on endodontic pain, the NRS can be verbally applied
without any visual aids. The 11 potentially differentiating
symptoms used in this communication were selected
based on the clinical experience of the investigators and
common textbook recommendations [20]. They have
been assessed, albeit not in the precise formulation
attempted here, in various previous studies to differenti-
ate between teeth of different clinical conditions [13,
28]. Pain intensity of endodontically involved teeth caus-
ing the patient to seek emergency care was investigated
in several previous studies [2, 7, 40, 42]. The current
mean NRS-11 pain levels between 7 and 8 correspond
well to those measured using a VAS scale on emergency
patients in previous studies [7, 42]. The current findings
confirm an earlier report in that pain intensity had no
differentiating value in the context of acute endodontic
conditions [7]. This was not the case for pain duration
though. Teeth affected by pulpits apparently hurt for
more than one week before the pain reached a level that
caused the patient to seek emergency care.
The current approach to facilitate the diagnostic deci-
sion between SAP and no SAP (SIP) has been two-fold.
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Initially, a prediction model including all available clin-
ical information was constructed to assess the discrim-
inative ability of the full checklist as measured with the
AUC. The resulting AUC was nearly 80 %, which is an
indication that the full model is in some degree valuable
for the distinction between patients with SAP and SIP.
However, the use of a prediction model based on 11 var-
iables may be difficult to implement in a clinical setting
unless a respective computer algorithm will be made
available, e.g., in the form of a software application. For
that reason, the decision tree analysis, which facilitates
the distinction into the groups of SAP and SIP following
a specific order of questions/key symptoms, was added
in a second step (Fig. 2). The overall sensitivity to detect
SAP based on the decision tree was 95 %. However, as is
typical for diagnostic decisions with a high sensitivity,
the resulting specificity of the tree was lower (31 %).
This result demonstrates that the decision tree can be
useful for cross-sectional studies. In a clinical setting,
the decision tree may be helpful to advise patients dur-
ing out-of hours calls.
Conclusions
This study confirmed that in severely painful teeth, the
most specific single symptom to differentiate between
SIP and SAP was pain to cold stimuli. In addition, how-
ever, decision analysis identified a set of key symptoms
to diagnose SAP also in teeth with a history of pain to
cold stimuli. If these felt too high and had hurt for less
than one week, the probability that SAP was diagnosed
was still 72 %.
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Abstract
Background and Objective
Pulpitis is mainly caused by an opportunistic infection of the pulp space with commensal
oral microorganisms. Depending on the state of inflammation, different treatment regimes
are currently advocated. Predictable vital pulp therapy depends on accurate determination
of the pulpal status that will allow repair to occur. The role of several players of the host
response in pulpitis is well documented: cytokines, proteases, inflammatory mediators,
growth factors, antimicrobial peptides and others contribute to pulpal defense mechanisms;
these factors may serve as biomarkers that indicate the status of the pulp. Therefore, the
aim of this systematic review was to evaluate the presence of biomarkers in pulpitis.
Methods
The electronic databases of MEDLINE, EMBASE, Scopus and other sources were
searched for English and non-English articles published through February 2015. Two inde-
pendent reviewers extracted information regarding study design, tissue or analyte used, out-
come measures, results and conclusions for each article. The quality of the included studies
was assessed using a modification of the Newcastle-Ottawa-Scale.
Results and Conclusions
From the initial 847 publications evaluated, a total of 57 articles were included in this review.
In general, irreversible pulpitis was associated with different expression of various biomark-
ers compared to normal controls. These biomarkers were significantly expressed not only in
pulp tissue, but also in gingival crevicular fluid that can be collected non-invasively, and in
dentin fluid that can be analyzed without extirpating the entire pulpal tissue. Such data may
then be used to accurately differentiate diseased from healthy pulp tissue. The interplay of
pulpal biomarkers and their potential use for a more accurate and biologically based diag-
nostic tool in endodontics is envisaged.
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Introduction
The dental pulp is equipped to express numerous mediators of inflammation, which can com-
bat irritating factors [1–4]. Its mechanistic response begins with vascular changes mediated by
Toll-like receptors (TLR) 4/2-positive cells and includes release of measurable inflammatory
mediators such as IL-8, IL-6, IL-1 and others [4–7]. Under normal physiologic conditions (left
in Fig 1), the vasculature consists of central vessels that branch out into a plexus towards the
periphery and specifically the pulp horns. An important difference from soft tissue-enclosed
portions of the body is that dental hard tissues enclose the pulp creating a low compliance
environment. Dental blood vessels are mainly under control by local metabolites and less by
sympathetic innervation. The main cellular components of the pulp are peripherally located
odontoblasts and stromal fibroblasts. There are also undifferentiated mesenchymal cells found
mainly in the paravascular niche and immune cells (Fig 1). In health, neutrophils predominate
but dendritic cells and occasional macrophages are also found.
Inflammation of the dental pulp (pulpitis) has been viewed as a tightly regulated sequence
of vascular and cellular events mediated by molecular factors [8]. Pulpitis is typically caused by
an opportunistic infection of the pulp space by commensal oral microorganisms [9]. The most
common route of entry for the microorganisms is dental caries. Other potential pathways for
pulpal microbial infection include trauma, dentinal cracks, exposed dentinal tubules or the
main apical foramen [10]. Cells in human dental pulp that express TLR contribute trigger
immune responses to microorganisms and their by-products [2–4]. This group includes odon-
toblasts [11], endothelial cells [12] as well as macrophages and dendritic cells [13]. Some of
these cells may form mechanical barriers (i.e. odontoblasts), detect and transmit sensations
(nerve fibers) or differentiate (i.e. dental pulp stem cells) to limit infection, signal injury and
promote repair, respectively.
Based on the patients’ signs, symptoms, and examination, four clinical pulpal conditions
are described: normal, reversibly inflamed, irreversibly inflamed or necrotic [14]. Histology
represents the gold standard to determine the inflammatory state of pulp tissue [15, 16]; how-
ever, it is generally agreed that histologic and clinical classification of pulpal diagnosis still
needs to be improved and refined. Normal and necrotic pulps have straightforward histologi-
cal presentation. The conundrum lies in differentiating reversible and irreversible pulpitis.
Fig 1. Schematic illustration of a tooth with a healthy pulp (left panel) and an inflamed pulp (right
panel) subjacent to a caries lesion. Involved factors and biological effectors are indicated for both pulpal
conditions.
doi:10.1371/journal.pone.0167289.g001
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Based on histological reports, reversible pulpitis is characterized by the absence of bacteria and
by localized coagulation and liquefaction necrosis immediately surrounding the irritant,
whereas irreversible pulpitis is characterized by the presence of the bacteria or their by-prod-
ucts in the dental pulp and by preponderance of acute inflammatory cells predominantly neu-
trophils in the tissue beneath the lesion suggesting chemotactic activity. Lysosomal enzymes
discharged by neutrophils result in widespread tissue damage and suppuration [16–18]. Acute
pulpitis (reversible, and irreversible) can be an extremely painful condition and is believed to
be one of the main causes for patients to seek emergency dental treatment during or after office
hours [19, 20]. The main clinical difference between reversible and irreversible pulpitis is in
the pulp’s response to thermal stimulus. Reversible pulpitis presents an exaggerated yet non-
lingering response to cold stimulus. Irreversible pulpitis on the other hand is characterized by
constant, spontaneous pain with exaggerated and lingering response to cold stimulus. How-
ever, forty percent of teeth with irreversible pulpitis can be painless [21]. In reversible pulpitis,
the pulp is expected to recover after removal of the causative stimulus. In contrast, if the pulp
is irreversibly inflamed, healing is not expected and pulpectomy (i.e., full removal of the dental
pulp) is indicated.
The succession of signaling events resulting from dental pulp stimulation by microorgan-
isms to the release of an array of immune mediators that in turn may cause pulpal or odonto-
genic pain, pulpitis, or in advanced stages, pulpal necrosis and finally apical periodontitis have
been well described in the past [4–7]. Detailed discussion of these mechanisms is beyond the
scope of this article.
Currently, diagnostic procedures that aim to assess pulpal inflammation involve case his-
tory, as well as clinical and radiographic examination. Clinical examination includes different
procedures such as inspection, pulp sensitivity to thermal or electric stimuli, and pain on pal-
pation or percussion. These procedures apparently did not change much in the last century
[22]. However, the validity of the currently employed clinical tests to determine the actual or
histopathological status of the pulp remains controversial [15]. A recently performed literature
review summarized the available information on the diagnostic accuracy of signs/symptoms
and current tests used to determine the condition of the pulp [23]. These authors concluded
that the overall evidence was insufficient to support the accuracy of such test, even if the tests
are combined. Hence, the current diagnostic procedures do not reliably identify the inflamma-
tory status of the pulp. This is particularly unfortunate since decision making in this field, for
example differentiation between vital pulp therapy and root canal treatment, critically depends
on an accurate pulpal diagnosis.
According to the National Library of Medicines, the medical subject heading term (MeSH
term) definition for a biological marker is a measurable and quantifiable biological parameter
that serves as an indicator for health- and physiology-related assessments. Molecules expressed
in the cascade of tissue inflammation may serve as (diagnostic) biomarkers for the presence of
inflammation. Some research suggests that the dental pulp is not an isolated entity in an
encased, solid environment but a reactive tissue that extends its biological products into the
outside environment [24, 25]. In fact, studies have shown that pulpal events can be reflected
through measurable levels of protein markers that correlated with pulpal symptoms in pulpal
blood [26], dentinal fluid [27], periapical fluid [28], and gingival crevicular fluid (GCF; [1, 29]).
In the field of periodontology, biomarkers in oral fluids/saliva or gingival crevicular fluid
are used to detect the occurrence and progression of periodontitis [30, 31]. For example,
matrix metalloproteinases (MMPs) such as MMP-8 and -9 have been shown to be central bio-
markers of soft tissue breakdown in periodontal pockets [32]. Periodontal and pulpal inflam-
mation shares certain features: initially, both exhibit soft-tissue inflammation caused by
microbial infection. At a later stage, these pathologic processes culminate in bone resorption
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(vertical bone-loss or apical periodontitis, respectively). It is therefore possible that both
pathoses may express the same biomarkers. In this regard, MMPs were shown to be potential
biomarker for both pulpal [33] and periodontal disease [32]. However, the application of
molecular diagnostics in pulpal disease is as yet not used for clinical decision-making [34].
Previous studies have investigated the molecular regulatory pathways of pulpal inflamma-
tion employing explanted cell cultures in vitro [35–37]. However, the extrapolation of such
results to the clinical situation is difficult, perhaps due to the reductionist nature of such exper-
iments. In vivo, the presence of other cellular players (e.g. immune cells), inhibitory proteins
(e.g. protease inhibitors) and other molecules that modify the inflammatory response may
present a completely different inflammatory response and consequently, a different clinical
outcome compared with what may be suggested by in vitro experimental results. Studies
reporting clinical samples for the presence of potential biomarkers for pulpal inflammation are
still on the rise. The clinical importance of identifying these biomarkers that can be used to
diagnose or to stage pulpal inflammation warrants not only additional studies but also a critical
or systematic review and analysis of published reports. Therefore, the aim of this paper is to
systematically review the currently available information on biomarkers that were identified
from pulp tissues diagnosed as normal or inflamed.
Systematic Review
Eligibility Criteria and Literature Search
This systematic review was prepared in accordance with PRISMA (S1 Table) [38]. Studies
were eligible for inclusion to the review that clinically and/ or histologically differentiate
between a healthy and a irreversibly inflamed pulp in permanent human teeth, and analyzed
interstitial/ dentinal liquor, gingival crevicular fluid, pulpal tissue, dentin fluid or apical blood
for the presence of a biological marker. A biological marker is defined as measurable and
quantifiable biological molecule that theoretically can be present in those substrates and might
serve as an indicator for a healthy or diseased pulp (adapted fromMeSH Unique ID:
D015415). An electronic search strategy with combined keywords and indexing vocabulary
(MeSH terms) was conducted in the Medline database of the US National Library of Medicine
employing the OvidSP interface. We used the following search terms and other subject head-
ings: ‘pulpitis’, ‘acute pulpitis’, ‘irreversible pulpitis’, ‘painful pulpitis’, ‘biological markers’,
‘inflammation mediators’, ‘dentinal fluid’, and ‘gingival crevicular fluid’. S2 Table lists the
detailed search strategy performed in Medline. The same electronic search strategy was used in
Biosis (OvidSP), the Cochrane library (Wiley), Embase (http://www.embase.com) and the
Web of Science (Thomson Reuters). The last date entered was February 19, 2015. No language
restrictions were imposed and all articles were included from the inception of the respective
database (S3 Table). To ensure the completeness of the search, one reviewer (DRK) conducted
a thorough search of the bibliographies of all included studies.
Study Selection and Quality Assessment
The search and selection process is summarized in Fig 2 [38]. A pool of 1733 records was ini-
tially identified using the electronic search strategy and other sources. After removal of dupli-
cates, 851 records remained. Two reviewers (DKR and JCG) independently screened the titles
and abstracts of the references collected. Communications not related to the topic were dis-
carded (n = 695). Communications deemed appropriate by one of the reviewers were assigned
for full text evaluation. One hundred and fifty-six records were identified using this approach
and reviewed as full texts. Articles were collected and evaluated independently by both review-
ers. Non-English abstracts or manuscripts were translated with the help of translators. Further
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articles (n = 99) were excluded for one of the following reasons: i) studies not on human teeth,
ii) cell culture study only, iii) no potential biomarker was investigated or the study was off
topic, iv) no clear distinction between reversible, irreversible or necrotic pulp, v) studies rather
on histologic features or presence of cells, bacteria or viruses than on quantification of a bio-
marker, vi) review articles, editorials, comments, abstract only or case reports (S4 Table). In
Fig 2. PRISMA flowchart depicting the systematic selection and exclusion of articles related to the topic. A detailed description of the
excluded articles with the respective reasons for exclusion is presented in the running text and S4 Table. From: Moher D, Liberati A, Tetzlaff J,
Altman DG, The PRISMA Group (2009). Preferred Reporting Iterns for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS
Med 6(7): e1000097. doi: 10.1371/journal.pmed1000097 For more information, visit www.prisma-statement.org.
doi:10.1371/journal.pone.0167289.g002
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case of disagreement consensus was achieved through discussion by third party arbitration
(OAP). Articles where no exclusion criteria applied were included to the review. There was
94.2% agreement prior to arbitration between both reviewers and finally 57 publications were
included to the review. The included articles were written in English (n = 54) or Chinese
(n = 3) language.
Quality Assessment
The quality of the included studies was assessed using a modification of the Newcastle-
Ottawa-Scale (NOS; [39, 40]). The NOS rates the 3 study domains ‘selection’, ‘comparability’
and ‘outcome’. Each positive rating was awarded with a star. The parameters recorded for
‘selection’ were: selection of the cohort (gender and age distribution reported) and condition
of the cohort (general health and medication reported). The parameters recorded for ‘compa-
rability’ were: diagnostics of cases and controls (anamnesis, clinical and radiological inspection
described in sufficient detail), histological confirmation of the diagnosis performed (yes/no),
quality of the controls (control sample from the same patient as the case sample) and the ratio
of the group size (cases:controls  1:2). The parameters recorded for ‘outcome’ were: reported
blinding to the case/control status (yes/no) and that the same tests were performed with the
cases and control samples (yes/no). Consequently two stars could be awarded for ‘selection’,
four stars for ‘comparability’ and two stars for ‘outcome’. A value of ‘0’ represents the lowest
study quality and ‘8’ the highest possible quality rating of the modified NOS.
Data Extraction and Statistical Analysis
Quantitative data were collected from all studies included to the review. An electronic protocol
for data extraction was defined and piloted on several manuscripts before final completion.
Relevant information regarding reference name, publication date, substrate analyzed for the
presence of a biological marker, how was the substrate collected, number of specimens in
experimental group and control group, was the substrate pooled before analysis (yes/no),
name of the biological marker under investigation, what type of molecule is the biological
marker, what general function serves the biological marker, what was the molecular expression
level of the biological marker, which analyte was evaluated for the presence of the biological
marker, which method was used for analysis, and were statistically significant differences
between specimens of the irreversible pulpitis group compared to the control group (healthy
pulp) reported (yes/no), were collected. The synthesis of the data is presented in a descriptive
manner. Moreover, descriptive statistics were applied when deemed appropriate (JMP 10.0.0,
SAS Institute, Cary, N.C., USA).
Results
Study Characteristics and Quality Assessment
The studies excluded during full text evaluation (N = 99; Fig 2) are presented in S4 Table. The
studies included in the review are listed in Tables 1 and 2. Due to the heterogeneous nature of
the studies it was not possible to perform meta-analysis on their outcome. The quality ratings
of the included studies according to the modified NOS are presented, along with the full refer-
ence, in S5 Table. The average quality score was 3.9 ± 1.1 (mean ± SD). Fig 3 provides an over-
view on the total ratings for the respective parameters for the study domains selection,
comparability and outcome. Weaknesses were noticed for the parameters selection of the
cohort, quality of the controls and reported blinding to the case/control status.
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Table 1. Studies assessing pulp tissue for the presence of biomarkers associated with pulpal condition.
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
Cytokines
Zehnder et al. 2003
[48]
11/13 IL-1α Regulates immune and inflammatory
reactions; stimulates bone resorption
mRNA PTS RT-PCR n
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 IL-1rα Acute phase protein that increases
neutrophil presence of
Protein PTS Multiplex
assay
y
Zehnder et al. 2003
[48]
11/13 IL-1β Regulates immune and inflammatory
reactions; stimulates bone resorption
mRNA PTS RT-PCR n
Paris et al. 2009 [50] 10/7 mRNA PTS RT-PCR y
Silva et al. 2009* [51] 5/5 Protein PTS ELISA n
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
Rauschenberger et al.
1997* [52]
15/17 IL-2 Regulates activities of leukocytes Protein PTS ELISA y
Anderson et al. 2002
[53]
32/24 Protein PTS ELISA n
Abd-Elmeguid et al.
2013* [49]
12/30 IL-4 Key regulator in humoral and adaptive
immunity; stimulates activated B cells,
T-cell proliferation, and the
differentiation of B-cells into plasma
cells
Protein PTS Multiplex
assay
y
Zehnder et al. 2003
[48]
11/13 IL-6 Regulator of T- and B-cell growth,
acute phase protein production
mRNA PTS RT-PCR y
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 IL-7 Stimulates proliferation and maturation
of B and T cells
Protein PTS Multiplex
assay
y
Huang et al. 1999*
[54]
14/15 IL-8 Recruitment and activation of
neutrophils
Protein PTS ELISA y
Zehnder et al. 2003
[48]
11/13 mRNA PTS RT-PCR y
Silva et al. 2009* [51]
*
5/5 Protein PTS ELISA n
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 IL-12p40 Subunit of IL-12; acts on T- and natural
killer cells
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 IL-13 Mediator of allergic inflammation and
disease
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 IL-15 Induces proliferation of natural killer
cells
Protein PTS Multiplex
assay
n
Zehnder et al. 2003
[48]
11/13 IL-18 Pro-inflammatory cytokine involved in
cell mediated immunity
mRNA PTS RT-PCR y
Pezelj-Ribaric et al.
2002 [55]
19/18 TNF-α Delays neutrophil apoptosis Protein PTS ELISA y
Kokkas et al. 2007 [43] 6/6 mRNA PTS RT-PCR y
Keller et al. 2009 [56] 5/5 mRNA PTS RT-PCR y
Paris et al. 2009 [50] 10/7 mRNA PTS RT-PCR y
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
(Continued )
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Table 1. (Continued)
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
Abd-Elmeguid et al.
2013* [49]
12/30 TNF-β Mediates a large variety of
inflammatory, immunostimulatory, and
antiviral responses
Protein PTS Multiplex
assay
n
Li et al. 2011* [57] 4/4 MIP-1α Mediate immune responses towards
infection and inflammation; activation
of granulocytes
mRNA PTS RT-PCR y
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
12/30 MIP-1β Mediate immune responses towards
infection and inflammation; activation
of granulocytes
Protein PTS Multiplex
assay
y
Nakanishi et al. 2005*
[58]
8/5 MIP-3α Chemoattractant for lymphocytes and
neutrophils
Protein FPT IHC n/a
Nakanishi et al. 2005*
[58]
8/5 CCR6 MIP-3αReceptor on memory T-cells,
dendritic cells and Th17 cells
Protein FPT IHC n/a
Abd-Elmeguid et al.
2013* [49]
12/30 TGF-α Induces epithelial development and
wound healing
Protein PTS Multiplex
assay
y
Piattelli et al. 2004*
[59]
20/23 TGF-β1 Modulates pro-inflammatory cytokine
production, inhibits mitogenic effects of
IL-2 on T and B lymphocytes, blocks
activity of other immunocompetent
cells
Protein FPT IHC y
Adachi et al. 2007*
[60]
9/4 CXCL10 Chemoattractant for monocytes/
macrophages, T cells, NK cells, and
dendritic cells
Protein PTS RT-PCR y
5/4 Protein FPT IHC n/a
Jiang et al. 2008* [61] 6/5 SDF-1 Chemotactic for lymphocytes mRNA PTS RT-PCR y
4/4 Protein FPT IHC n/a
Huang et al. 2009*
[62]
15/15 Oncostatin M Involved in hematopoiesis, tissue
remodelling processes and
inflammation
mRNA PTS RT-PCR y
Protein FPT IHC y
Abd-Elmeguid et al.
2013* [49]
12/30 GM-CSF Stimulates production of granulocytes
and monocytes
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
GRO Neutrophil chemoattractant. Involved in
angiogenesis, inflammation, wound
healing and tumorigenesis
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
MCP-1 Chemoattractant for monocytes,
recruits memory T cells, and dendritic
cells to the sites of inflammation
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
MCP-3 Chemoattractant for monocytes;
regulates macrophage function
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
MDC Chemotactic for monocytes, dendritic
cells and natural killer cells
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
INF-α Antiviral agents, modulate functions of
the immune system
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
G-CSF Stimulates proliferation and
differentiation of granulocytes
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
Eotaxin-1 Recruits eosinophils by inducing their
chemotaxis
Protein PTS Multiplex
assay
y
(Continued )
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Table 1. (Continued)
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
Abd-Elmeguid et al.
2013* [49]
flt3ligand Stimulates proliferation and
differentiation of various blood cell
progenitors
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
Fractalkine Chemoattractant for T cells and
monocytes; promotes strong adhesion
of leukocytes to activated endothelial
cells
Protein PTS Multiplex
assay
y
Abd-Elmeguid et al.
2013* [49]
CD40L Co-stimulatory molecule for T cells;
promotes B cell maturation and
function
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
sIL-2rα Receptor that mediates IL-2 activities;
increased levels biological fluids
correlate with increased immune
system activation
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
IP-10 Chemoattractant for monocytes/
macrophages, T cells, NK cells, and
dendritic cells
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
PDGF-AA Receptor that regulates cell
proliferation, cellular differentiation, cell
growth and development
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
PDGF-AB/BB Receptor that regulates cell
proliferation, cellular differentiation, cell
growth and development
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
RANTES Chemoattractant for leukocytes to
inflammatory sites; proliferation and
activation of natural-killer cells
Protein PTS Multiplex
assay
n
Abd-Elmeguid et al.
2013* [49]
Osteocalcin Regulation of bone mineralization Protein PTS Multiplex
assay
y
Protein FPT IHC n/a
Proteases and other enzymes
Gusman et al. 2002
[63]
17/18 MMP-1 Regulator of connective tissue
remodeling
Protein PTS ELISA Not detected
Gusman et al. 2002
[63]
17/18 MMP-2 Hydrolysis of intercellular matrix Protein PTS ELISA y
Accorsi-Mendonca
et al. 2013 [64]
10/10 Protein PTS Zymography y
Accorsi-Mendonca
et al. 2013 [64]
10/10 pro-MMP-2 Pro-form of MMP-2 Protein PTS Zymography n
Gusman et al. 2002
[63]
17/18 MMP-3 Hydrolysis of intercellular matrix Protein PTS ELISA y
Tsai et al. 2005* [65] 14/14 mRNA PTS RT-PCR y
Protein FPT IHC y
Gusman et al. 2002
[63]
17/18 MMP-9 Hydrolysis of intercellular matrix;
regulatory factor for neutrophil
migration across basement membrane
Protein PTS ELISA y
Suwanchai et al. 2012
[66]
7/18 Protein PTS Western
Blot
y
Accorsi-Mendonca
et al. 2013 [64]
10/10 Protein PTS Zymography n/a
Huang et al. 2005*
[67]
17/13 t-PA Involved in soft-tissue breakdown;
catalyzes the conversion of
plasminogen to plasmin
mRNA PTS RT-PCR y
(Continued )
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Table 1. (Continued)
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
Protein FPT IHC n/a
Huang et al. 2007*
[68]
22/9 Protein PTS Zymography y
22/9 Protein PTS ELISA y
Ge et al. 1996 [69] 12/9 SOD Antioxidant Protein
activity
PTS Enzyme
assay
y
Tulunoglu et al. 1998
[70]
10/7 Protein
activity
PTS Enzyme
assay
n
Bodor et al. 2007 [71] 16/10 Cu, ZN-SOD Protection against reactive oxygen
species
mRNA PTS RT-PCR y
Varvara et al. 2005
[72]
13/12 Protein
activity
PTS Enzyme
assay
y
Bodor et al. 2007 [71] 16/10 Mn-SOD Protection against reactive oxygen
species
mRNA PTS RT-PCR y
Ge et al. 1996 [69] 12/9 MDA Oxidative stressor Protein
activity
PTS Enzyme
assay
y
Cootauco et al. 1993*
[73]
5/8 Elastase Cleavage of elastin, collagen,
proteoglycans
Protein FPT IHC y
Cathepsin-G Proteolysis Protein FPT IHC y
Spoto, Fioroni, Rubini,
Tripodi, Di Stilio, et al.
2001 [74]
10/10 Alkaline
phosphatase
Hydrolysis of phosphate ester-bonds Protein
activity
PTS Enzyme
assay
n
Spoto, Fioroni, Rubini,
Tripodi, Perinetti, et al.
2001 [75]
20/20 Aspartate
Aminotransferase
Catalyzes transfer of aminotransferase
amino group of aspartate to α-
ketoglutarat
Protein
activity
PTS Enzyme
assay
n
Esposito, Varvara,
Caputi, et al. 2003 [76]
15/18 Catalase Catalyzes the breakdown of hydrogen
peroxide
Protein
activity
PTS Enzyme
assay
y
Esposito, Varvara,
Murmura, et al. 2003
[77]
12/11 Protein
activity
PTS Enzyme
assay
y
da Silva et al. 2008*
[78]
6/6 NADPH-
diaphorase
Detoxification to produce ROS Protein FPT IHC y
Di Nardo Di Maio et al.
2004* [79]
10/10 eNOS Nitric oxide synthase mRNA PTS RT-PCR y
Protein PTS Western blot y
Protein FPT IHC y
10/10 iNOS Nitric oxide synthase mRNA PTS RT-PCR y
Protein PTS Western blot y
Protein FPT IHC y
Spoto, Ferrante, et al.
2004 [80]
6/12 cGMP PDE Hydrolysis of cyclic nucleotide Protein
activity
PTS Enzyme
assay
y
Spoto, Menna, et al.
2004 [81]
6/12 cAMP PDE Hydrolysis of cyclic nucleotide Protein
activity
PTS Enzyme
assay
y
Accorsi-Mendonca
et al. 2013 [64]
10/10 TIMP-2 Inhibits MMP-2 Protein PTS ELISA y
MPO Generation of reactive oxygen species Protein
activity
PTS Enzyme
assay
y
Inflammatory mediators
Bolanos and Seltzer
1981 [82]
17/7 cAMP Activation of protein kinases Protein PTS RIA n
(Continued )
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Table 1. (Continued)
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
cGMP Activation of protein kinases Protein PTS RIA n
Cohen et al. 1985 [47] 13/20 PGE2 Multiple pro-inflammatory and
immunomodulatory effects
Protein PTS† RIA y
PGF2α Multiple pro-inflammatory and
immunomodulatory effects
Protein PTS† RIA y
Cootauco et al. 1993*
[73]
5/8 α-2M Neutralization of proteinases Protein IHC n/a
Dong et al. 1999 [83] 9/11 6-K-PGF1α Vasodilators; inhibits the aggregation
of blood platelets; involved in
inflammation
Protein PTS RIA y
TXB2 Involved in platelet aggregation,
vasoconstriction and reproductive
functions
Protein PTS RIA y
Khabbaz et al. 2001
[84]
15/5 Endotoxins Induces strong immune response Protein
activity
PTS LAL y
Nakanishi et al. 2001*
[85]
10/5 COX-2 Prostaglandin synthesis Protein IHC n/a
Guven et al. 2007*
[86]
12/12 Protein FPT IHC n/a
Awawdeh et al. 2002
[87]
46/20 Substance P Vasoactive mediator, immune mediator Protein PTS RIA y
Caviedes-Bucheli et al.
2006 [88]
6/6 Protein PTS RIA y
Awawdeh et al. 2002
[87]
46/20 Neurokinin A Generates three different
preprotachykinins
Protein PTS RIA y
Caviedes-Bucheli et al.
2006 [88]
6/6 Protein PTS RIA y
Awawdeh et al. 2002
[87]
46/20 CGRP Vasodilation and increased
microvascular permeability
Protein PTS RIA y
Caviedes-Bucheli et al.
2004 [89]
5/5 Protein Pulp cells
in
suspension
Flow
cytometry
y
Caviedes-Bucheli et al.
2005 [90]
6/4 Protein PTS RIA y
Caviedes-Bucheli et al.
2006 [88]
6/6 Protein PTS RIA y
Caviedes-Bucheli et al.
2006 [88]
6/6 Neuro-peptide Y Potent vasoconstrictor,
parasympathetic nervous system
Protein PTS RIA y
VIP Vasodilator, parasympathetic nervous
system
Protein PTS RIA n
da Silva et al. 2008*
[78]
6/6 NOD2 Involved in host response against
bacteria
mRNA PTS RT-PCR y
Keller et al. 2009 [56] 5/5 mRNA PTS RT-PCR y
Growth Factors
Artese et al. 2002*
[91]
25/25 VEGF Stimulates vasculogenesis and
angiogenesis
Protein FPT IHC n/a
Guven et al. 2007*
[86]*
12/12 Protein FPT IHC n/a
Abd-Elmeguid et al.
2013* [49]
12/30 Protein PTS Multiplex
assay
n
(Continued )
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Tissues Studied
Eighty-eight percent of the studies included (50/57; Table 1) analyzed pulp tissue for the pres-
ence of a biomarker either collected via pulpectomy (N = 5), tooth extraction and fracturing
(N = 25), or a combination of both (N = 20). Twelve percent (7/57; Table 2) of the studies
included analyzed substrates other than pulp tissue: pulpal blood (N = 2), peripheral blood
serum (N = 1), GCF (N = 1), dentinal fluid (N = 1), or extracellular pulpal fluid (N = 2). Pulpal
blood, GCF and dentinal fluid were collected using absorbable membranes, blood serum via
peripheral blood collection and extracellular pulpal fluid by inserting microdialysis mem-
branes into vital pulp tissue [41, 42]. Eighty-two percent of the studies analyzing pulp tissue
Table 1. (Continued)
Reference n per group
(irreversibly
inflamed/
non-inflamed)
Biomarker Function Target Analyte Method Significant
difference
between
groups
Abd-Elmeguid et al.
2013* [49]
12/30 FGF Involved in angiogenesis, wound
healing, embryonic development and
various endocrine signaling pathways
Protein PTS Multiplex
assay
n
Antimicrobial peptides
Paris et al. 2009 [50] 10/7 hBD-1 Activates the innate and adaptive
immune system. Chemotactic for
monocytes, T-lymphocytes, dendritic
cells and mast cells
mRNA PTS RT-PCR y
hBD-2 mRNA PTS RT-PCR n
hBD-3 mRNA PTS RT-PCR n
hBD-4 mRNA PTS RT-PCR y
Others
Caviedes-Bucheli et al.
2007 [92]
5/5 Substance P
receptor
Vasoactive mediator, immune mediator Protein PTS RIA y
Caviedes-Bucheli,
Moreno, et al. 2008
[93]
13/13 AAMø CD163
+ expressing
CGRPr
Alternatively activated polarized
monocyte/macrophage; different
phenotype compared to the classical
ones. Then expressing CD163+
Protein Pulp cells
in
suspension
Flow
cytometry
See text
Suwanchai et al. 2012
[66]
7/18 NaV 1.8 Initiation and propagation of action
potentials; involved in pain perception
Protein PTS Western blot y
NaV 1.9 Initiation and propagation of action
potentials; involved in pain perception
Protein PTS Western blot y
Zhong et al. 2012 [94] 18/12 miRNAs Regulators of post-transcriptional gene
expression in biological processes like
inflammation, immune response, and
osteoclastic bone resorption
mRNA PTS Microarray See text
Dong et al. 2013* [95]
*
21/12 EphA7 Involved in embryonic development,
angiogenesis, tumorigenesis,
inflammation & pain
Protein FPT IHC y
mRNA PTS RT-PCR y
* Pulpal inflammation confirmed histologically;
† Substrate pooled before analysis;
y: Yes; n: No; n/a: Not applicable.
Analytes were mostly either pulp tissue supernatant (PTS) or fixed pulp tissue (FPT). One study used pulp cells in suspension, another one pulpal fluid.
Analytical methods used included reverse transcription polymerase chain reaction (RT-PCR), multiplex assay, microarray, Western Blot,
radioimmunoassay (RIA), immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), zymography, flow cytometry, limulus amoebocyte
assay (LAL), and specific enzyme assays.
doi:10.1371/journal.pone.0167289.t001
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(41/50) used tissue collected from extracted healthy, non-carious permanent, or wisdom teeth
as their control. Fourteen percent (7/50) used healthy pulp tissue collected via pulpectomy
because of elected root canal treatment for prosthetic reasons as their control. One study used
tissues from extraction and pulpectomy as control [43], another one did not state precisely
how they collected control tissue [2]. Of the 7 studies evaluating substrates other than pulp tis-
sue, two sampled blood [44, 45], and another one extracellular fluid [41] from healthy teeth
that were assessed but subsequently planed for extraction because of prosthetic or orthodontic
reasons as control. One study sampled venous (peripheral) blood during pulp inflammation
and used a consecutive peripheral blood sample after treatment as control [46]. One further
study sampled GCF from healthy contralateral or adjacent teeth as control [1], and another
one collected dentinal fluid from non-symptomatic teeth scheduled for replacement of a filling
as control [33]. The substrate in one study was pooled before performing the confirmatory test
[47].
Confirmatory Tests
Analytical methods used for the assessment of pulp tissue included reverse transcription poly-
merase chain reaction, multiplex assay, microarray, western blot, radioimmunoassay, immu-
nohistochemistry, enzyme-linked immunosorbent assay, zymography, flow cytometry,
limulus amoebocyte assay and specific enzyme assays (Table 1). Pulpal inflammation was con-
firmed by histology in 42% (21/50; Table 1 and S5 Table) of these studies. Substrates other
than pulp tissue were analyzed using radioimmunoassay, enzyme-linked immunosorbent
assay, specific serum, or enzyme assays (Table 2). Histology was not used to confirm pulpal
diagnosis in those studies. Seventy-four percent of the studies evaluating pulp tissue (37/50)
analyzed actual protein expression or protein activity, whereas 16% (8/50) analyzed the pulp
tissue on the DNA level. Five studies (10%) analyzed the pulp tissue substrates at both levels
(Table 1). All studies evaluating other substrates than pulp tissue evaluated protein expression
or protein activity (Table 2).
Markers Studied
Pulp tissue was assessed for a total of 89 biological markers. Statistical significant differences
between an irreversible inflamed and a healthy pulp could be detected for 64 biological mark-
ers (71.9%) by at least one study. Nineteen biological markers showed no statistically signifi-
cant differences between inflammation and health, whereas 6 biological markers were not
evaluated employing statistical tests (Table 1). Substrate other than pulp tissue was evaluated
for 16 biological markers. For twelve biological marker (75%) statistical significant differences
between irreversible inflammation and health could be detect by at least one study.
Discussion
The results point to a response in pulpitis by immunocompetent tissues that ultimately results
in the release of mediators, which in turn trigger a series of inflammatory events and an
attempt to initiate repair. Collectively, the data presented here demonstrate the involvement of
various TLR-induced chemotactic molecules (i.e. IL-8, CXCL-10, MIP family, GRO, MCP
family, RANTES, Eotaxin, IP10, and others).
TLRs have been shown to confer immunocompetence to the dental pulp [56]. They are
expressed by both immune and non-immune cells in the pulp including neurons, fibroblasts,
endothelial cells, epithelial cells and others, which recognize viral and microbial structures as
well as self molecules (such as single stranded RNAs) that may accumulate in non-physiologic
amounts or sites during inflammation [96–100].
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Table 2. Studies assessing other substrates than pulp tissue for the presence of a biomarker.
Reference n in group
(irreversibly
inflamed/ non-
inflamed)
Biomarker Function Target Analyte Analysis Significant
difference
between groups
Cytokines
Nakanishi
et al. 1995
[44]
27/9 IL-1α Regulates immune and inflammatory
reactions; stimulates bone resorption
Protein PB ELISA n
IL-1β Regulates immune and inflammatory
reactions; stimulates bone resorption
Protein PB ELISA n
Elsalhy et al.
2013 [45]
43/25 IL-2 Regulates the activities of leukocytes Protein PB ELISA n
Nakanishi
et al. 1995
[44]
27/9 IL-6 Regulator of T- and B-cell growth,
acute phase protein production
Protein PB ELISA Not detected
Elsalhy et al.
2013 [45]
43/25 Protein PB ELISA y
Karapanou
et al. 2008 [1]
17/17 IL-8 Recruitment and activation of
neutrophils
Protein GCF ELISA y
Elsalhy et al.
2013 [45]
43/25 Protein PB ELISA y
Elsalhy et al.
2013 [45]
43/25 IL-10 Multiple effects in immunoregulation
and inflammation; anti-inflammatory
Protein PB ELISA y
Nakanishi
et al. 1995
[44]
27/9 TNF-α Delays neutrophil apoptosis Protein PB ELISA n
Karapanou
et al. 2008 [1]
25/25 Protein GCF ELISA Not detected
Elsalhy et al.
2013 [45]
43/25 Protein PB ELISA y
Elsalhy et al.
2013 [45]
43/25 IFN-γ Cytokine that is critical for innate and
adaptive immunity
Protein PB ELISA y
Proteases and other enzymes
Zehnder et al.
2011 [33]
16/12 MMP-9 Hydrolysis of intercellular matrix;
regulatory factor for neutrophil
migration across basement
membranes
Protein
activity
Dentinal fluid Enzyme
assay
y
Nakanishi
et al. 1995
[44]
27/9 Elastase Cleavage of elastin, collagen,
proteoglycans
Protein PB ELISA y
Vasoactive agents
Lepinski et al.
2000 [41]
11/10 Bradykinin Vasodilator involved in pain and
inflammation mechanisms
Protein Extracellular
pulpal fluid
RIA y
Bowles et al.
2003 [42]
16/8 Protein Extracellular
pulpal fluid
RIA y
Others
Nakanishi
et al. 1995
[44]
27/9 IgG Antigen neutralization Protein PB ELISA y
Nakanishi
et al. 1995
[44]
27/9 IgA Antigen neutralization Protein PB ELISA y
Nakanishi
et al. 1995
[44]
27/9 IgM Antigen neutralization Protein PB ELISA y
(Continued )
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Under normal conditions, very few immune cells are present in the dental pulp [101]. In
the presence of infection (i.e. caries), immune cells are recruited to the pulp even in the absence
of direct bacterial contact on the pulp tissue itself. The permeability of dentin to soluble bacte-
rial products allows pulpal response to occur prior to carious pulpal exposure. These soluble
bacterial products, along with components of the complement system and products of the
lipoxygenase pathway of arachidonic acid metabolism are chemotactic for leukocytes [102].
The exponential increase in the number of infiltrating leukocytes brings with it a corre-
sponding increase in lysosomal enzymes that cause tissue damage. Proteases like elastase and
MMPs (Tables 1 and 2) cleave elastin and proteoglycans that destroy the pulp tissue resulting in
irreversible damage [33, 58, 63]. Furthermore, the accompanying spike in inflammatory media-
tors like PGE2, cAMP, COX-2, CGRP, neurokinins and others stimulate vasodilation and
microvascular permeability by binding into their respective receptors (i.e. EP2/3 receptor for
PGE2) and induce cytoskeletal rearrangement or contraction of vascular smooth muscle [103].
Table 2. (Continued)
Reference n in group
(irreversibly
inflamed/ non-
inflamed)
Biomarker Function Target Analyte Analysis Significant
difference
between groups
Nakanishi
et al. 1995
[44]
27/9 PGE2 Multiple pro-inflammatory and
immunomodulatory effects
Protein PB ELISA y
Evcil et al.
2006 [46]
16/16 Serum NO Cellular signaling molecule involved in
many physiological and pathological
processes
Protein
activity
Peripheral
blood serum
Serum
assay
n
y: Yes; n: No.
Analytes were mostly either pulpal blood (PB) or gingival crevicular fluid (GCF). Extracellular pulpal fluid and peripheral serum were used in one study each.
Analytical methods used included radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), and specific serum or enzyme assays.
doi:10.1371/journal.pone.0167289.t002
Fig 3. Bar chart showing the quality ratings of the included studies based on a modified Newcastle-
Ottawa-Scale.
doi:10.1371/journal.pone.0167289.g003
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Equally as important is the action of neuropeptides (e.g. substance P, calcitonin-gene
related peptide) (Table 1). These neuropeptides typically reside in endings of afferent nerve
close to blood vessels but also associated with macrophages and odontoblasts [104]. As a
response to stimuli, afferent nerve sprouting has been demonstrated, and with it an increase in
neuropeptide concentration [105], which can cause spontaneous pain, allodynia or hyperalge-
sia in teeth with pulpitis.
Simultaneous to the destructive effects of leukocytic infiltration is the capability of these
cells to induce repair through the release of VEGF, TGF-B, GM-CSF and others (Tables 1 and
2) that induce alterations of the local extracellular matrix, promote induction of endothelial
cells to migrate or proliferate, and inhibition of vascular growth with formation of differenti-
ated capillaries [106]. The increased expression in inflamed pulp of toll-mediated human beta-
defensins (hBD) [50] that play an important role in the innate host defense against bacterial
invasion, contribute to promotion of adaptive immune responses, and show chemotactic activ-
ities further underscore the dynamic range of response of the dental pulp during inflamma-
tion. In addition, it can also be appreciated that during pulpal inflammation, the anti-
inflammatory effects of various mediators such as tissue inhibitors of matrix proteinases
(TIMPs), siRNA [94, 107] and others also come into play.
As a direct result of the release of inflammatory biomarkers, pulpal responses include classi-
cal signs of inflammation specifically a vascular response, along with changes in mediator pro-
files and cellular constituents. The transition from reversible to irreversible pulpitis has been
broadly characterized by a migration of dendritic cells towards odontoblasts and accumulation
of immune cells [108]. However, a more detailed analysis such in the majority of studies
included in this paper evaluating biomarkers of pulpal inflammation demonstrates (statistical)
significant differences between a clinically diagnosed healthy or irreversibly inflamed pulp at
the molecular level.
Moreover, the analytes were obtained via different approaches both from the pulp directly
as well as indirectly from tissue fluid. Fig 4 illustrates the potential sampling sites for molecular
pulpal diagnostics [34]. While having the benefit to show a direct picture of intrapulpal condi-
tions using pulpal blood [26] or whole pulp tissue requires access to the pulp space and is
Fig 4. Actual and potential sampling sites to assay pulpal mediators.
doi:10.1371/journal.pone.0167289.g004
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therefore not applicable as a chairside screening tool. Conversely, indirect methods such as
dentin fluid collection or assessment of mediators in GCF can be performed clinical in a less
invasive way. Dentin fluid is the extracellular fluid that is contained within dentinal tubules
[109]; its composition includes inflammatory mediators and vasoactive compounds associated
with inflammation. While initial evidence suggested that these mediators can be assayed [33]
problems exist with protein yield [27] and the need to remove the existing restoration or in
other cases to prepare an initial cavity deep in dentin.
GCF was used to sample mediators in one study included here (Table 2) [1]. This fluid is an
exudate that from the gingival crevice and it contains several host factors including antibodies,
bacterial antigens, proteins, and cytokines [110, 111]. GCF analyses may be promising due to
the ease of application. Moreover, it may be possible to assess the dynamics of apical periodon-
titis using GCF [34]. However, the major drawback in the evaluation of host mediators in GCF
is that tissue inflammation, independent of its cause, is a non-specific process of innate immu-
nity [112] and this makes it difficult to distinguish on a molecular level between a marginal
and apical periodontal inflammation. When sampling from the GCF for pulpal diagnostics,
this potential drawback could be overcome by (i) creating healthy periodontal conditions, (ii)
averaging out several sites on one or multiple teeth, (iii) combining clinical and radiographic
observations, or (iv) defining a specific pattern of metabolites relevant to the pulp and not the
periodontium, or possibly by other as yet unidentified means. Furthermore, the detection of
mediators of pulpitis in GCF is impacted by the need for these compounds to reach the peri-
odontal ligament and ultimately the gingival crevice in sufficient concentrations. Indeed, the
notion that mediators will diffuse from the pulp via dentinal tubules or accessory canals to the
periodontal ligament has been called into question [87]. Periapical fluid samples, while requir-
ing a direct access to the apical site, are of interest to determine the level of systemic inflamma-
tion [28].
Discovering an improved method to determine the present inflammatory condition of the
pulp could be of great value: on the one hand, pulp necrosis is one of the most frequent com-
plications after coronal restoration of assumed non-inflamed (vital) teeth, on the other per-
forming a full pulpectomy on teeth that could have been kept vital (at least in part) suggests
that overtreatment may occur in many cases [113]. Endodontic diagnosis should therefore
focus on either the extent of the microbial infection or the inflammatory reaction of the host
tissue; however, current methods do neither [14, 23, 34].
Keeping a pulp vital offers distinct advantages compared to root canal treatment: the pro-
tective immune capacity of the pulp remains preserved and the remaining tooth structure gets
not unnecessarily weakened by access cavity preparation and root canal enlargement. Unfortu-
nately, the only available long-term outcome studies on direct pulp capping procedures (i.e.
direct pulpal interventions), which attempt to maintain pulpal vitality, show unsatisfactory
success rates as low as 20% after ten years [114]. The development of biocompatible materials
facilitates a wound closure free of inflammation after pulpal capping procedures or partial pul-
potomy [108]. However, the likelihood of a pulp to survive such procedures remains question-
able using current schemes for assessment of pulpal inflammation.
One limitation of this systematic review is that merely 2 out of 57 studies [33, 45] were spe-
cifically designed to investigate potential biomarkers in the context of pulpal diagnostics. Most
of the studies analyzed here merely target the presence of molecules and their function in
pulpal inflammation. Nevertheless, based on the current state of knowledge this review pro-
vides an overview on molecules that are present and measurable during pulpal inflammation
and therefore potentially can serve as a biomarker for pulpal inflammation. This may provide
impulses for further research. This research needs to explore patient (age, gender, systemic
condition) and infection related factors (varying composition of the microbiological
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infection). Clinical investigations should be conducted that are specifically designed to confirm
the results collected from the research collected here. More specifically mediator profiles
should be assessed in defined clinical scenarios. In addition, the assays methodology should be
tested for their applicability with the possible substrates. The ultimate goal should then be to
develop an inexpensive chairside test for non-invasive molecular pulp diagnostics. In fact,
such a chair-side assay, based on the immunochromatographic detection of MMP-8 specific
antibodies, is already commercial available to diagnose periodontal inflammation [115]. For
endodontic procedures of the future, such as partial pulpotomies and pulp regeneration, a
comparable test will be of significant value.
Indeed, various biomarkers that are produced by cellular components of the dental pulp
can provide a snapshot of the biological mechanisms that propel this immunocompetent tissue
towards healing or necrosis. The imbalance between tissue destructive molecules like proteases
and tissue inductive molecules like VEGF may serve as a diagnostic or prognostic tool for end-
odontic intervention. The challenge remains on developing a method to make these biomark-
ers readily measureable in a clinical setting.
Conclusions
In the included studies, irreversible pulpitis was associated with different expression of various
biomarkers compared to non-inflamed controls. These biomarkers were significantly
expressed not only in pulp tissue, but also in gingival crevicular fluid that can be collected
non-invasively and in dentin fluid that can be analyzed without extirpating the pulpal tissue.
This may be used to accurately differentiate diseased from healthy pulp tissue. The main cur-
rent challenges in the clinical application of biomarkers lie in the identification of biomarkers
or biomarker subsets that reliably correlate with pulpal inflammation, the improvement of
sample collection (substrate and protein yields), and their analysis (interference of the bio-
markers with inflammation of other than pulpal origin). If these hurdles can be overcome, a
more accurate pulpal diagnosis and more predictable vital pulp treatment regime may create
better clinical outcomes.
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1. Introduction
A recent systematic review identified sparse evidence regard-
ing the accuracy of current pulp tests.1 When a tooth contains
an allegedly vital pulp before it is restored, the dentist has but
few means to decide whether to perform a root canal
treatment prior to restoration or not. This may explain why
pulp necrosis is the most common biological complication in
abutment teeth.2,3
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Objectives: To test the hypothesis that a material with higher water absorption than
polyvinylidene fluoride (PVDF) could increase the yield of target molecules from exposed
dentine.
Methods: In a series of standard tests, different cellulose membranes were compared to a
PVDF counterpart for their ability to absorb water and release protein. In a subsequent
randomized clinical trial, the cellulose material with the most favourable values was
compared to PVDF regarding the levels of MMP-2 that could be collected from exposed
dentine of healthy human teeth during filling replacement. MMP-2 levels were determined
by enzyme-linked immunosorbent assay (ELISA). Data from the laboratory experiments
were compared betweenmaterials using the appropriate parametric tests. The frequency of
cases yielding quantifiable levels of MMP-2 was compared between materials by Fisher’s
exact test. The level of significance was set at 5%.
Results: The cellulose membrane with the largest pore size (12–15 mm) absorbed significant-
ly (P < 0.05) more water than PVDF. It showed a protein release that was similar to that of
PVDF, while the cellulose membranes with smaller pore size retained significantly more
protein (P < 0.05). Using the large-pore cellulose membrane, MMP-2 could be collected at a
quantifiable level from the dentine of healthy teeth in 9 of 13 cases, compared to 1 of 13 with
the PVDF membrane (P < 0.05).
Conclusions: Under the current conditions, a large-pore cellulosemembrane yieldedmore of
a molecule of diagnostic value compared to a standard PVDF membrane.
Clinical significance: Molecular diagnostics of dentinal fluid are hampered by low yields. In
the current study, it was shown that cellulosemembranes are more useful to collect MMP-2
from dentinal fluid than PVDF membranes.
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A novel experimental approach to non-invasively identify
the state of the pulp is molecular diagnostics.4 It is based on
the collection and analysis of dentinal fluid.5,6 However, the
collectionof dentinal fluid is not unproblematic. Thefluid and
protein flux across the pulpodentine complex is influenced by
multiple factors.5 In addition, a simple and clinically useful
tool for dentinal fluid collection is currently not available. In
the first trial on the levels of matrix metalloproteinase-9
(MMP-9), an enzyme associated with pulpal breakdown,7 a
folded polyvinylidene fluoride (PVDF) filter membrane was
applied to exposed dentine for dentinal fluid collection. This
was based on the excellent protein release from PVDF.8
However, the first clinical study using this approach showed
that the target protein was below the detection limit in the
majority of the samples, also those that should contain it. It
was concluded that better vehicles for dentinal fluid collec-
tion must be identified to increase the yield of target
molecules before further studies can be performed along
this line.
It was the aim of the current investigation to test the
hypothesis that a material with higher water absorption than
PVDF could increase the yield of target molecules from
exposed dentine. In standard laboratory tests, cellulose filter
membranes of similar thickness and different pore size were
compared to the PVDF membrane used in the first clinical
trial4 regarding their water absorption and protein release.
Subsequently, the cellulose membrane with the most favour-
able values was compared to the PVDF counterpart in a
randomized clinical trial. The outcomemeasure was the yield
of a metalloproteinase from exposed dentine of clinically
healthy teeth in need of restoration replacement. The
hypothesis tested here was that cellulose membranes absorb
more water than PVDF counterparts, and thus could increase
the yield of diagnostically relevant molecules.
2. Materials and methods
2.1. Filter membranes under investigation
Three types of cellulose membranes were compared. They
were Sartorius 1288, 1289, and 1290 (Sartorius Stedim Biotech
GmbH, Go¨ttingen, Germany). These filter membranes were
available as sheets, which were required for the water
absorption test (below). They had a standard thickness of
0.21 mm and a pore size of 12–15 mm (1288), 8–12 mm (1289),
and 3–5 mm (1290). The PVDF membrane under investigation
(Merck Millipore, Billerica, MA, USA) had a thickness of
0.125 mm and a pore size of 0.45 mm.
2.2. Water absorption
For this test, themethod according to Klemmwas used (DIN 53
106). In brief, the filter membranes were cut to a width of
1.5 cm and a length of 10 cm. One end of these strips was
attached to a custom-made holder. For measurements, the
holder was placed over a glass container filled with deionized
water, so that the membrane strips were immersed 2 mm
below the water surface. The height of the water rise was
marked with a sharp pencil on the membranes after 30 s, 60 s,
and 120 s of immersion. This test was performed three times
per material.
2.3. Protein release
For this test and the subsequent trial, round filtermembranes
with a diameter of 8 mm were used. Using a micro precision
pipette (Gilson, Middleton, UK), 5 mL of a 2 mg/mL bovine
serum albumin (BSA) solution (Pierce, Rockford, USA) was
blotted on the membranes. Subsequently, membranes were
transferred to microcentrifuge tubes (Eppendorf, Hamburg,
Germany) containing 1 mLof sterile distilledwater. The tubes
were vortexed for 5 s. Subsequently, each membrane was
transferred to a newmicrocentrifuge tube and again washed
in 1 mL of distilled water as described. The procedure was
repeated oncemore for a total of threewashing steps. Protein
recovery was measured using a commercially available
protein assay (BCA Protein Assay Kit, Pierce) against a
BSA standard curve. The absorbance at 562 nm was
measured using a microplate reader (Epoch, BioTek, Luzern,
Switzerland). Measurements were corrected for blank read-
ing (mere membrane without protein processed as
described).
2.4. Clinical trial
This trial was approved by the institutional review board
(Canton of Zu¨rich Ethics Commission). The patients partici-
pating did so by giving informed written consent.
Sartorius 1288 filter membranes were compared to Milli-
pore PVDF counterparts for their capacity to collect a
metalloproteinase from exposed dentine of clinically healthy
teeth in need of filling replacement. MMP-2 was chosen as the
target molecule, because this enzyme is involved in normal
tissue turnover and thus present in healthy pulp tissue.7 The
membranes were folded to form a cone as described.4 They
were kept in micro centrifuge tubes with low protein binding
(Life Technologies, Carlsbad, CA, USA). The membranes and
tubes were sterilized in ethylene oxide (3M Sterigas, Two
Harbors, MN, USA).
Thirteen lateral teeth from 8 patients (6 males and 2
females, aged 29–56) were selected for this study. These teeth
reacted normal to cold test, and showed no signs of caries or
inflammation. They required replacement of a filling for
prosthetic or aesthetic reasons. Teethwere treated under local
anaesthesia and rubber dam isolation. The occlusal aspect of
the filling reaching into the dentine was removed first, i.e. the
inter-proximal aspects of the fillings were left in place, to
exclude contamination with crevicular fluid. Diamond-coated
burs were used in a high-speed hand piece under water-
cooling to remove the old filling. When the dentine was
exposed, a coinwasflipped to determinewhichmaterial to use
first. The cavitywas driedwith compressed air. Thereafter, the
first folded membrane was applied to the exposed dentine
using sterile cotton pliers (Fig. 1). The membrane was kept in
place for 30 s. Subsequently, and without any intermediate
procedure, the second membrane of the alternative material
(as defined by the randomization process) was applied for 30 s.
Membranes were immediately transferred to their microcen-
trifuge tubes, which were kept on ice. These tubes were then
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transferred to a freezer and kept at !20 8C until further
analysis.
On the day of analysis, the sampleswere eluted in 330 mL of
sterile phosphate buffered saline (PBS, pH 7.2) by centrifuging
at 2000 " g for 30 min at 4 8C. The levels of MMP-2 in these
samples were measured by a commercially available specific
enzyme-linked immunosorbent assay (ELISA) kit, according to
the manufacturer’s instructions (Duoset, R&D Systems,
Abingdon, UK). The absorbance at 450 nm was assessed using
a microplate reader (Epoch), with a wavelength correction set
at 570 nm to subtract background. A standard curve was
generated using a four-parameter logistic curve fit for each set
of samples assayed. The concentrations of MMP-2 were
expressed as ng/mL/30 s of collection. The sensitivity of this
assay, defined as the lowest detectable protein concentration
that could be differentiated from zero, was 1.25 ng/mL.
2.5. Statistics
Values relating to water absorption were analysed using two-
way repeatedmeasures ANOVA to consider the impact of time
and membrane type on water rise. Water rise at each time
point and protein release were compared between materials
using one-way ANOVA followed by Tukey’s HSD test. The
frequency of detection of MMP-2 in the clinical trial between
materials was compared using Fisher’s exact test. MMP-2 data
from the clinical trial was skewed (Shapiro–Wilk test) and thus
compared between groups using Wilcoxon Signed Rank test.
The alpha-type error was set at 5% (P < 0.05).
3. Results
In the analysis of the values generated in the water absorption
test according to Klemm, two-way ANOVA showed that both
time and membrane material had a significant (P < 0.05)
impact on water rise. Cellulose membranes took up water
faster and in larger quantity than the PVDF material under
investigation (Table 1). The cellulose materials with the larger
pore size showed higher water absorption than the filter
membrane with the small pore size.
Protein release was statistically similar (P > 0.05) between
the cellulose materials with the large pore size (Sartorius 1288
and 1289) and the PVDF membrane. After 3 wash steps, 1288
released 93 # 9% of the BSA, 1289 released 96 # 3%, and the
PVDF membrane 101 # 4%. The cellulose material with the
small pore size (1290) released significantly (P < 0.05) less
protein, 81 # 4%.
In the clinical trial, the cellulose material that performed
most favourably in the laboratory screening (1288) was
compared to the PVDF filter membrane regarding the detec-
tion of MMP-2 from exposed dentine of clinically healthy teeth
with vital pulps. Round membranes of 8 mm diameter were
folded to form tapered cones. The cone was pressed against
the exposed dentine using cotton pliers. The materials were
applied to the exposed dentine in randomsequence during the
trial, 1 membrane per material and tooth. With cellulose,
MMP-2 could be detected in 9 of 13 cases, compared to 1 of 13
with PVDF (P < 0.05). Consequently, the levels of MMP-2 were
Fig. 1 – Collection of dentinal fluid from exposed dentin using a folded PVDF membrane. Left panel reproduced with
premission from an earlier publication (4).
Table 1 – Height of water rise at different times in mm
(Klemm method).
Membrane 30 s 60 s 120 s
Sartorius 1288 21.7 # 1.2A 31.0 # 1.0A 37.7 # 0.6A
Sartorius 1289 20.0 # 1.0A 31.0 # 4.4A 37.7 # 0.6A
Sartorius 1290 14.0 # 1.7B 17.7 # 2.1B 20.0 # 0.0B
Millipore PVDF 9.0 # 0.0C 13.0 # 0.0C 20.0 # 0.0B
Values indicate means and standard deviations of triplicates. Two-
way repeated measures ANOVA showed that both time and
membrane had a significant (P < 0.05) impact on water rise. Data
sets sharing a superscript letter did not differ significantly at a
given point in time (one-way ANOVA, Tukey’s HSD).
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significantly higher (P < 0.05) when a cellulosemembrane was
used to collect dentinal fluid (Fig. 2). MMP-levels were
statistically similar (P > 0.05) between first and second collec-
tions, indicating no influence of whether a membrane
material was used first or second on a specific tooth (Fig. 3).
4. Discussion
The current study showed that cellulose of large pore size
showed clear advantages over PVDF in dentinal fluid collec-
tion. This was attributed to the better water absorption of
cellulose compared to PVDF.
The clinical part of this study was limited by the fact that
only clinically healthy teeth were included. This was done to
assess the possibility to consistently collect steady-state
molecules present in pulpal interstitial fluid. While the
cellulose membrane under investigation performed clearly
better than the PVDF membrane that was used in a first trial,4
the target molecule was still not detected in 30% of the cases.
This could be related to differences in dentine microstructure
between the teeth under investigation.9 It may be so that
dentinal fluid collection is simply not possible in all teeth,
especially those with complete sclerosis of dentine.10 Howev-
er, the repeated collection with the 2 different materials
yielded similar amounts of the target molecule (Fig. 3). This
would suggest that in future trials, at least 2 sampling
procedures should be performed per tooth in order to increase
fluid yield. Alternatively, the membrane used for collection
could also be left in place for longer periods of time. As
suggested by the in vitro part of the current communication,
exposing a filter membrane to water for 1 min instead of 30 s
may lead to better water uptake. A further limitation of this
study was the low number of teeth under investigation.
However, we merely compared 2 methods of dentinal fluid
collection in healthy teeth. Based on the in vitro results, a
difference between the 2 methods of more than 50% in
absolute MMP-2 levels was expected. As indicated by the
highly significant difference between the 2 methods, this
assumption was correct, and the number of samples was
adequate.
Absorbency of the vehicles used for dentinal fluid collec-
tion may play a role because the natural flow of fluid through
dentine is rather low.5 It may be so that the cellulose
membrane actively soaked more fluid from the dentine
wound than the PVDF membrane did. Dentinal fluid flow is
related to pulpal pressure.11 This pressuremight vary based on
the inflammatory state of the underlying pulp.12 However,
even necrotic teeth contain dentinal fluid.13 Using the
cellulose membrane technique described here, we were able
to collect MMPs from teeth with necrotic teeth also (data not
shown). Consequently, absorption of fluid through dentine by
cellulose may be necessary to get maximum yields regardless
of the condition of the pulp. This, however, needs to be
investigated in future trials.
In the current study, a simple ELISA assay was used. In the
first trial on MMP-9 levels in the dentinal fluid of healthy and
inflamed pulps, amore sensitive, yet alsomore complex assay
was employed, which detects the target molecule indirectly
via substrate turnover.4 That assay detected MMP-9, a
molecule related to pulpal tissue breakdown, in the dentinal
fluid of 7 out of 16 teeth diagnosed with irreversible pulpitis,
compared to 0 of the 12 healthy control teeth. That first study
should now be repeated to investigate whether the use of a
cellulose material for dentinal fluid collection would allow for
sample analysis with straightforward ELISA kits, or whether
Fig. 2 – Dot plot depicting the MMP-2 yields from the two
different filter membranes under investigation. Materials
were applied to exposed dentin for 30 s. There was a
significant difference in MMP-2 yields between the two
materials under investigation (Wilcoxon Signed Rank test,
P = 0.0023).
Fig. 3 – Dot plot relating MMP-2 yields to the sequence the
filter membranes were applied in the clinical trial. There
was no difference in yield whether a membrane was
applied first or second (Wilcoxon Signed Rank test, P > 0.05).
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more sensitive assays are still required. However, even though
the kit used here is easy to use, the current approach to
analyse dentinal fluid would still be far away from chair-side
practicability in a dental office setting.
As the field ofmolecular diagnostics of the pulp is relatively
new, basic studies such as the current investigation are
necessary to identify ideal and simple tools for the collection
of dentinal fluid. Dentinal fluid could, for a long time, only be
collected from extracted teeth, e.g. by heating the dentine or
by centrifugation.14,15 In the original study on dentinal fluid
analysis of vital human teeth, phosphate-buffered saline was
placed in the cavity over the exposed dentine for 15 min and
then collected using micropipettes.6 Similar approaches were
also used to study dentinal fluid flux in dog teeth.5,11 These
collection methods, however, are impracticable in the clinical
situation. The current research aimed towards the develop-
ment a chair-side assay that could reflect the health of pulp
before a tooth is restored. Whether this goal can ever be
achieved is not yet clear. Nevertheless, current knowledge on
pulp biology and sensitive molecular assays could prove to be
useful in this context. It is beyond doubt that pulpal
breakdown is triggered by bacterial invasion of dentine,16
yet propagated by enzymes secreted by polymorphonuclear
leukocytes (PMNs).17 The idea to use PMN-associated enzymes
as markers for pulpal health was formulated, yet not tested,
more than 20 years ago.5 In this context, the MMP system of
enzymes is interesting. Some of these enzymes are produced
by resident cells.18 They are related to normal tissue turnover,
and are thus not elevated or even less active in inflamed pulps
compared to normal counterparts.7 On the other hand, PMN-
related enzymes such as MMP-9 (also called neutrophil
gelatinase), are strongly correlated to pulpal inflammation
and breakdown.7 It may thus be suggested to use the ratio
between MMP-9 and MMP-2 in future clinical trials to relate
dentinal fluid composition to the state of the pulp. It must be
cautioned, however, that MMPs are also contained in the
dentine itself, and can be released by caries-related acids.19,20
Furthermore, proteins of varying size and structure might be
retained differently during their passage through the pulp–
dentine complex.5 It may thus be wise to investigate the levels
of different proteins and their relation to different conditions
of the pulp to identify the most robust markers. In summary,
much work lays ahead to further develop dentinal fluid-based
diagnostics.
5. Conclusion
The identification and development of better vehicles for
dentinal fluid analysis is essential for the propagation of non-
invasive molecular diagnostics of the dental pulp. This
research can be seen as a first step into that direction. Future
clinical trials should now reveal whether a cellulose mem-
brane is a suitable collection tool to consistently identify
marker molecules related to pulpal health and disease.
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a b s t r a c t
The dental pulp space can become infected due to a breach in the surrounding hard tissues. This leads to
inflammation of the pulp (pulpitis), soft tissue breakdown, and finally to bone loss around the root apex
(apical periodontitis). The succession of the molecular events leading to apical periodontitis is currently
not known. The main inflammatory mediator associated with neutrophil chemotaxis is interleukin-8 (IL-
8), and with bone resorption the dyad of receptor activator of NF-jB ligand (RANKL) and osteoprotegerin
(OPG). The levels of RANKL, OPG and IL-8 were studied in periapical tissue fluid of human teeth (n = 48)
diagnosed with symptomatic irreversible pulpitis (SIP) and asymptomatic apical periodontitis (AAP). SIP
represents the starting point, and AAP an established steady state of the disease. Periapical tissue fluid
samples were collected using paper points and then evaluated using enzyme-linked immunosorbent
assays (ELISAs). Target protein levels per case were calibrated against the corresponding total protein
content, as determined fluorometrically. RANKL was expressed at significantly higher levels in SIP com-
pared to AAP (P < 0.05), whereas OPG was under the detection limit in most samples. In contrast, IL-8 lev-
els were significantly lower in SIP compared to AAP (P < 0.05). Spearman’s correlation analysis between
RANKL and IL-8 revealed a significantly (P < 0.05) negative correlation between the two measures
(rho = !.44). The results of this study suggest that, in the development of apical periodontitis, periapical
bone resorption signaling, as determined by RANKL, occurs prior to inflammatory cell recruitment signal-
ing, as determined by IL-8.
! 2014 Elsevier Ltd. All rights reserved.
1. Introduction
The oral cavity is a unique environment, where hard tissue
structures (teeth) breach a soft tissue barrier into a space replete
with microorganisms. Consequently, when the microorganisms
manage to overcome this barrier, an opportunistic infection can
occur. Examples of opportunistic oral infections include caries, peri-
odontitis, and apical periodontitis [1]. Apical periodontitis is fairly
common in adults, with roughly one in three individuals affected
[2]. As any other opportunistic infection, apical periodontitis is
characterized by a complex interplay between microbial
tissue invasion and host defense [3]. In the course of pulpal
inflammation, the soft tissue inside the root canal system is
digested by proteolytic enzymes, which are produced by neutro-
phils [4,5]. Unless the entryway for the microorganisms into the
pulp space is blocked by intervention [6], the whole canal system
can gradually become infected, and an inflammatory lesion estab-
lishes around the apical region to keep this infection under control
[7]. One histo-pathologic endpoint of periapical inflammation is
bone loss, which may occur to increase vascularization at the por-
tals of the apex, thus blocking the infection in the root canal space
from affecting the host [7,8].
The primary line of defense against microorganisms is the
innate immune system. Pulpal and later periapical inflammatory
responses are characterized by the influx of neutrophils [7]. The
main molecules associated with neutrophil recruitment and acti-
vation to the site of infection is interleukin-8 (IL-8, CXCL8) [3].
IL-8 is produced at local sites of inflammation and has been asso-
ciated with pulpal breakdown and apical periodontitis [9,10]. Per-
iapical bone loss is a hallmark of apical periodontitis. On the
molecular level, bone resorption is orchestrated by the interplay
of receptor activator of NF-jB ligand (RANKL) and osteoprotegerin
http://dx.doi.org/10.1016/j.cyto.2014.05.014
1043-4666/! 2014 Elsevier Ltd. All rights reserved.
Abbreviations: IL, interleukin; RANKL, receptor activator of NF-jB ligand; OPG,
osteoprotegerin; SIP, symptomatic irreversible pulpitis; AAP, asymptomatic apical
periodontitis.
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(OPG). The presence of RANKL activates its cognate RANK receptor
and stimulates differentiation of precursor cells into osteoclasts.
On the contrary, the OPG soluble decoy receptor blocks RANKL,
hence preventing its interaction with RANK, and therefore inhibits
osteoclast activation and subsequently bone resorption [11,12].
The RANKL–OPG system is clearly involved in the pathogenesis
of periodontal disease, and its relative RANKL/OPG ratio can indi-
cate the occurrence, yet not the progression, of the disease [13].
Since apical periodontitis is also characterized by bone loss, it is
fair to postulate a role of this bi-molecular system in the pathogen-
esis of this disease as well. Indeed, a recent comprehensive review
has summarized the information available of the RANKL–OPG sys-
tem in the context of pulpal and periapical disease, identifying a
lack of conclusive information [14].
What is currently not known in the context of periapical inflam-
mation and bone resorption, is the succession of the molecular
events that culminate in bone resorption or inflammatory cell
recruitment. It is hypothesized that themolecular activation of bone
resorption in the periapical region, hence the regulation of RANKL
andOPG, shouldprecede the chemotactic signals that lead to inflam-
matory cell recruitment, as evaluated by the regulation of IL-8.
Therefore, it was the aim of the current study to investigate the per-
iapical tissue fluid levels of RANKL, OPG and IL-8 in teeth with
inflammation restricted to the pulp space, and compare these to
counterparts from teeth with an established periapical inflamma-
tory lesion.
2. Materials and methods
2.1. Patients, operative procedures and periapical fluid collection
This study was approved by the Ethics Review Board of the Can-
ton of Zürich (KEK-ZH-No. 2011-0253/4) and was conducted in
accordance with the guidelines of the World Medical Association
Declaration of Helsinki. It is confirmed that this cross-sectional
study conforms to STROBE guidelines for observational studies.
All patients were treated at the Department of Preventive Den-
tistry, Periodontology and Cariology, University of Zürich, Center
of Dental Medicine, Switzerland by one operator specialized in
endodontics (DKR). The participants were in need of a root canal
treatment. They were either referred for the treatment or attended
the department’s emergency unit during service hours. The
patients were asked to participate in the study when they were
of full age (P18 y) and were excluded from the study if they: (i)
refused to participate in the study, (ii) were under long-term
anti-inflammatory medication, immunosuppressive chemotherapy
or any antibiotic medication, (iii) were not systemically healthy
(i.e. suffer from cardiovascular and respiratory disease, diabetes
mellitus, HIV infection or hepatitis), or (iv) were pregnant or in lac-
tation. The clinical condition was diagnosed according to the
patient’s case history, clinical inspection, palpation, tenderness to
percussion, vitality testing, probing depth and radiographic exam-
ination (single-tooth radiograph, Digora, Soredex, Tuusula, Fin-
land). The clinical conditions included in the study were
symptomatic irreversible pulpitis (SIP) with normal apical tissues
and pulp necrotic or previously treated teeth with asymptomatic
apical periodontitis (AAP) as defined by the American Association
of Endodontists [15]. The patients who entered the study gave
written informed consent. All operative procedures were per-
formed using a dental microscope under suitable magnification.
For root canal treatment the patient’s teeth were anesthetized with
4% articain (Septanest, Septodont, Saint-Maur-des-Fossés Cedex,
France) and isolated with rubber dam. The work field was wiped
with a cotton pellet soaked with 3% sodium hypochlorite (Kan-
tonsapotheke, Zürich, Switzerland) for surface disinfection. When
caries was present, it was excavated with round burs and a pre-
endodontic build-up placed if deemed appropriate. The endodontic
access was prepared with a sterile diamond-coated bur and the
root canals were instrumented using ProTaper instruments
(Maillefer Dentsply, Ballaigues, Switzerland) according to the man-
ufacturer’s recommendations. Endodontic working length was
determined endometrically (Root ZX mini, J Morita Corp., Tustin,
CA, USA) with a hand file (Maillefer Dentsply). The diagnosed clin-
ical condition (SIP or AAP) was confirmed during instrumentation
by assessing the content of the root canal for the presence or
absence of vital tissue. The root canals were instrumented up to
their apical constriction, under continuous manual irrigation with
1% sodium hypochlorite (Kantonsapotheke) using a syringe with a
side-vented needle (Hawe Irrigation Probe, gauge no. 30, Kerr
Hawe, Bioggio, Switzerland) one millimeter shorter than the pre-
determined working length. A size-15 hand file was frequently
used to keep the apical foramen patent. After instrumentation to
ProTaper F2, five mL of sterile physiological saline solution (.9%,
B. Braun Medical AG, Sempach, Switzerland) were administered
to full working length to inactivate possible remnants of NaOCl.
After drying the root canal with sterile paper points a fine paper
point (Orbis Dental, Münster, Germany) was inserted approxi-
mately 2 mm above the apical foramen to collect the periapical tis-
sue fluid [16]. The paper point was kept in that position for 30 s
and was then transferred into a sterile micro-centrifugation tube
(Biopure 1.5 ml, Vaudaux-Eppendorf AG, Schönenbuch, Switzer-
land). Three paper points were collected from one canal and imme-
diately after frozen at !80 "C until further processing. Only one
root canal per tooth/patient has been sampled as described above.
In case of multi-rooted teeth diagnosed with AAP one root corre-
sponding with the radiographic lesion was sampled whereas in
cases of multi-rooted teeth diagnosed with SIP the sampled canal
was chosen randomly. After the periapical fluid collection the root
canal treatments were finished lege artis.
2.2. Sample preparation
For the laboratory analysis, a protease inhibitor (complete mini
EDTA free, Roche, Basel, Switzerland) was added to sterile phos-
phate buffered saline (PBS, pH 7.2) and the samples were re-eluted
in 300 ll of this mixture. The micro-centrifugation tubes were
placed for 5 h on a platform shaker at (2000 rpm) at 4 "C. After-
wards, the tubes were vortexed for 30 s and thereafter centrifuged
for 10 min at 5000 rpm. The supernatant was collected and trans-
ferred into new micro-centrifugation tubes before being processed
on 96-well plates for subsequent enzyme-linked immunosorbent
assay (ELISA) analyses, while the resulting pellet was stored.
2.3. ELISA assays for RANKL, OPG and IL-8
The total amountof RANKLandOPG in theperiapical supernatant
was determined byhuman-specific ELISA according to themanufac-
turer’s instructions (total sRANKL ELISA and Osteoprotegerin ELISA
kits, Immundiagnostik AG, Bensheim, Germany). The concentra-
tions of IL-8 in the supernatantwere evaluatedusing a commercially
available ELISA kit (DY208, Duo Set Human CXCL8/IL-8 ELISA, R&D
Systems, Abingdon,UK). Absorbancewasmeasured at 450 nmusing
a microplate reader (Epoch, BioTek, Lucerne, Switzerland), with
wavelength correction of 620 nm for RANKL and OPG, and 570 nm
for IL-8. A standard curve was created by a four-parameter logistic
(4-PL) equation, using knownconcentrations of the rhRANKL, rhOPG
and rhIL-8 standards, all provided in the corresponding ELISA kits.
The concentrations of RANKL, OPG and IL-8 in all periapical fluid
supernatants were calculated against these standard curves. Addi-
tionally, the concentrations of these analytes were also calibrated
against the total protein content in each sample. Total protein in
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the periapical supernatant was quantified using a Qubit 2.0 Fluo-
rometer (Life Technologies, Carlsbad, CA, USA), as recommended
by the manufacturer.
2.4. Statistics and data presentation
To compare differences between clinical diagnosis groups
regarding categorical variables (gender, tooth type, or jaw), the
Chi-Square test was used. Normality of the data related to continu-
ous variables was checked by the Shapiro–Wilk test. These data sets
were skewed, and therefore for comparison between groups,Mann–
WhitneyU testwasused. CorrelationbetweenRANKLand IL-8 levels
was evaluated by the Spearman’s correlation analysis. Statistically
significant differencewas considered at the level of P < 0.05. Contin-
uous variables are presented as medians and interquartile ranges
(IQRs).
3. Results
3.1. Patient demographics and samples evaluated
Fifty-eight patients (n = 58) were recruited between September
2011 and May 2013. Periapical tissue fluid samples were collected
from all patients, as described above. Ten samples could not be fur-
ther analyzed for the following reasons: (i) problems with the sam-
pling procedure (i.e. severe blood contamination or it was
impossible to sufficiently reach the periapical area with the paper
point, n = 7), (ii) association with pus (i.e. pus discharge from the
root canal, n = 3). The remaining 48 samples were distributed SIP
(n = 21) and AAP (n = 27) among the different clinical diagnosis.
The ratio between female and male patients was 29/19 and the
patient’s age ranged between 18.0 and 80.5 years. Twenty-eight of
the samples included were from molar teeth, 12 from premolars
and 8 collected from anterior teeth. Twenty-six teeth were located
in the maxilla and the remaining 22 teeth in the mandible. With
regards to categorical variables, there were no statistically signifi-
cant differences between the diagnostic groups when compared
regarding gender, tooth type, or tooth location (P > 0.05). Age of
patientswas also similar between groups, with no significant differ-
ence (P > 0.05).
3.2. Determination of RANKL, OPG and IL-8 levels in periapical fluid
The total protein concentration was first investigated, in order
to evaluate if there were any quantitative differences in sampling
amounts between the diagnostic groups. These were (median,
IQR) 166 (154, 223) mg/ml in SIP and 182 (154, 257) mg/ml in
AAP, and the difference proved to be statistically non-significant
(Fig. 1A, P > 0.05). The levels of RANKL calibrated to total protein
were further investigated. RANKL was detected in 20 of 21 samples
in SIP (95%) and in 24 of 27 samples with AAP (88%). The median
RANKL level for SIP was 1456 pg/mg total protein (IQR: 774–
2567 pg/mg total protein). This was significantly (P < 0.05) higher
in SIP than in AAP with 829 pg/mg total protein (IQR: 263 to
1785 pg/mg total protein; Fig. 1B). On the other hand, OPG was
barely detected in any of the periapical fluid samples, namely in
5 of 21 samples with SIP (24%), and 3 of 27 samples with AAP
(11%). The low frequency of OPG detection prohibited any mean-
ingful statistical analysis to determine differences between both
groups. Moreover, due to the same reason, it was not possible to
deduce the relative RANKL/OPG ratio in these samples.
The levels of IL-8 in the periapical fluid samples, calibrated to
total protein, were investigated next. IL-8 was detected in 9 of 21
sampleswith SIP (43%) and 20 of 27 sampleswithAAP (74%). Periap-
ical fluid samples of teeth with SIP exhibited significantly (P < 0.05)
lower levels of IL-8 (median = not detected, IQR: not detected – 23
pg/mg protein) than in AAP (median = 106, IQR: not detected –
1340 pg/mg total protein; Fig. 1C). Spearman’s correlation analysis
between the levels of RANKL and IL-8 in both conditions (values nor-
malized to total protein) revealed a significantly (P < 0.05) negative
correlation between the two measures (rho = !.44).
4. Discussion
In this study the periapical molecular inflammatory response to
an opportunistic microbial infection was investigated. The findings
Fig. 1. Quantitative expression of total protein (A), RANKL (B) and IL-8 (C) in
periapical tissue fluid samples of teeth diagnosed with symptomatic irreversible
pulpitis (SIP) and asymptomatic apical periodontitis (AAP). Total protein concen-
tration (mg/ml) was determined fluorometrically (Qubit 2.0). Samples from SIP and
AAP proved to be statistically similar (P > 0.05). RANKL concentration was deter-
mined by human-specific ELISA calibrated against the total protein content of each
individual sample (pg/mg). RANKL levels were significantly higher in samples from
SIP when compared to AAP (P < 0.05). IL-8 concentration was determined by
human-specific ELISA calibrated against the total protein content of each individual
sample (pg/mg). Periapical fluid samples of teeth with SIP exhibited significantly
(P < 0.05) lower levels of IL-8 than AAP.
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demonstrate that at the starting point of apical periodontitis, as rep-
resented in SIP, where the inflammation is still confined to the root
canal space, high levels of RANKL, but low levels of IL-8 are detect-
able in the periapical tissue fluid. In contrast, when an apical lesion
is established and a chronic state of the inflammation has emerged,
as is the case of AAP, significantly more IL-8, but less RANKL is pres-
ent at the periapex. These findings strongly suggest, that in the
kinetics of apical periodontitis, periapical bone resorption signaling,
regulated by the RANKL/OPG system takes place prior to inflamma-
tory cell recruitment mediated by IL-8, according to the hypothesis
of the present study.
There are advantages employing apical periodontitis models for
studying inflammatory responses such as a readily quantifiable end-
point of apical tissuedestruction and the development of the pathol-
ogy in a circumscribed area [8]. However, in previous studies the
kinetics of apical periodontitis has been investigated mainly
employing rodent models where the pulp gets exposed to the oral
environment [17]. Pro-inflammatory cytokines, such as IL-1 and
TNF-a, are expressed at a very early stage of the disease in rodent’s
periapical tissues [18]. Especially IL-1plays a pivotal role indevelop-
ment andprogression of apical periodontitis [8]. In addition, both IL-
1 andTNF-a arepotent inducersof chemokine’s furtherdownstream
such as IL-8. Nevertheless, the role of IL-8 remains unclear using
rodent models, particularly because one major difference between
the human andmurine immune system is that IL-8 is not expressed
by the latter [19]. In humans, IL-8 is synthesized instantaneously at
local sites of infections by a variety of tissue cells e.g. endothelial
cells or fibroblasts. Highmolecular levels of IL-8 have been detected
in inflamed human pulps and chronic apical lesions immunohisto-
chemically [9] and in periapical exudate of teeth with symptomatic
andasymptomatic apical periodontitis engagingmolecularmethods
[20]. Collectively, these earlier observations are in agreement with
the results of the present study, whereby IL-8 is detected in AAP,
and at particularly higher levels, compared to the healthy apical tis-
sue in SIP.
Another crucial biological process of apical periodontitis, namely
bone resorption, was also evaluated in the periapical tissue fluid
samples of this study. This was achieved bymeasuring the presence
and levels of the RANKL–OPG system,which is of relevance to pulpal
and periapical pathosis, particularly by initiating the molecular
events that lead to osteoclastogenesis [14]. However, OPG could
be detected in 17% of the samples. One possible explanation for this
observation couldbe, that themajor source forOPG is connective tis-
sue [13], which is not that prominent in the tight periapical region,
especially once the dental pulp has been removed, as was in the
present case. Nevertheless, molecular mechanisms of bone resorp-
tion could still be assessed by the presence of RANKL in the periap-
ical tissue fluid. RANKL was detectable in both groups and was
significantlyhigher expressed in cases diagnosedwith SIP compared
to AAP. Some studies reported significantly more RANKL-positive
cells [21] and RANKL mRNA expression [22] for chronic apical
lesions compared to their controls. However, healthy apical peri-
odontal ligament cells scraped of teeth extracted for orthodontic
reasons frequently served as negative controls, which is not optimal
for comparison with cells from the periapical region. Accordingly, a
limitation of the present study was that due to ethical consider-
ations it is not possible to collect control samples fromhealthy teeth.
Yet, the presence of RANKL at higher levels in the apical tissue fluid
from teeth with SIP compared to AAP confirmed in this study, indi-
cates a higher regulation of bone resorption signaling events at the
early, rather than the established, stages of apical periodontitis.
5. Conclusions
In conclusion, the early periapical presence of RANKL in teeth
with SIP, along with the higher presence of IL-8 at the later stage
of AAP, as well as the negative correlation between these two mea-
sures indicates a reverse cascade of molecular events according to
the stage of the apical periodontitis. At early stages, there is an acti-
vation of bone resorption to allow the expansion of the inflamma-
tion to the periapical region. At later stages, when the bone lesion
has occurred to accommodate the inflammatory infiltrate, there is
instead active chemotactic signaling that may contribute to the
chronicity of periapical inflammation. These molecular characteris-
tics of periapical pathologies should be taken into consideration, as
markers for monitoring the different stages of apical periodontitis,
or as potential targets for adjunctive therapeutic treatment.
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a b s t r a c t
The bacterial phylum Synergistetes consists of Gram-negative anaerobes. Oral Synergistetes are divided in
two main clusters, namely A and B. Increasing evidence demonstrates their involvement in etiology of
oral infections, including apical periodontitis. This condition causes bone loss around the apex of the
tooth, subsequent to pulp inﬂammation (pulpitis). Although the presence of Synergistetes has been
conﬁrmed in endodontic infections by molecular methods, these have not been morphologically iden-
tiﬁed in the affected apical region, and their prevalence among different endodontic infections has not
been determined. Therefore, the aim of this study was to evaluate the prevalence, levels and morphology
of oral Synergistetes clusters A and B, in apical root canal samples obtained of teeth with irreversible
pulpitis, pulp necrosis and apical periodontitis, or previously root-ﬁlled teeth with apical periodontitis.
For their detection, ﬂuorescence in situ hybridization and epiﬂuorescence microscopy were used. Syn-
ergistetes cluster A was not detected in pulpitis, but was found in both apical periodontitis groups, more
frequently and at higher ranges in teeth which were previously root-ﬁlled. Microscopically, they
appeared as straight or slightly curved long rods. Synergistetes cluster B was not detected in any of the
cases. Fusobacteria and Actinomyces, which are well-established taxa in endodontic infections, were
detected more frequently and at higher ranges than Synergistetes. In conclusion, Synergistetes cluster A
constitutes part of the mixed apical microbiota in apical periodontitis, and may be involved in its
pathogenesis.
! 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Synergistetes is a recently identiﬁed bacterial phylum consisting
of Gram-negative anaerobes. They are found in several microen-
vironments and constitute part of the human microbiota in health
and disease [1e4], including the oral microbiota [5]. Phylogeneti-
cally, the oral Synergistetes are divided principally into clusters,
namely cluster A and cluster B [2,3]. Considerable work on the role
of Synergistetes has beenmade in the ﬁeld of periodontal infections.
They are detected more frequently and more abundantly in sub-
gingival plaque from periodontitis-affected than healthy sites [2],
or in the saliva of patients with periodontitis, compared to
healthy individuals [6]. Accordingly, dental plaque from
periodontitis-affected sites exhibits higher clonal abundance and
diversity of Synergistetes, in comparison to healthy sites [7]. The
presence of Synergistetes in dental plaque is also more pronounced
in necrotizing ulcerative gingivitis, compared to plaque-induced
gingivitis [8].
Widespread oral infections, such as caries, periodontitis, and
apical periodontitis, are of largely opportunistic nature [9]. Apical
periodontitis (AP) is the outcome of endodontic infection. It is very
prevalent among adults, with an estimated one-third of the pop-
ulation being affected [10]. The initial steps of the disease involve
the microbial invasion and inﬂammation of the pulpal tissue
(pulpitis), primarily as a result of dental caries [11,12]. Persistent
inﬂammation inside the root canal system causes degradation of
the pulpal tissue [13] and allows for the progression of the end-
odontic infection. Histopathologically, this leads to the establish-
ment of an inﬂammatory lesion in the bone around the apical
region of the tooth, which is characteristic of AP, aiming to
keep under control the recurring infection in the root canal system
[14].
Synergistetes have been frequently detected at elevated numbers
in root canals of teeth with chronic endodontic infections, such as
AP, as identiﬁed by polymerase chain reaction (PCR)-based
methods and sequencing analyses [15,16]. The size of the total
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Synergistetes population in necrotic teeth with AP is reported to
range between 104 and 106 16S rRNA gene copies, while their
proportion constitutes <1.0% of the total microbial community,
allegedly within the detection range of other pathogens charac-
teristic of endodontic infections [17]. Yet the differential presence
of Synergistetes clusters A and B in the apical region of teeth with
various clinical endodontic diagnoses has not been determined.
Hence, the aim of this study was to evaluate the prevalence, levels
and morphology of oral Synergistetes clusters A and B, in apical
samples obtained of teeth with irreversible pulpitis but normal
apical tissues, pulp necrotic teeth with AP, or previously root-ﬁlled
teeth with AP. Comparatively, the presence of Fusobacteria and
Actinomyces was also evaluated, as these are well-established taxa
in mixed endodontic infections.
2. Materials and methods
2.1. Patients, procedures and sample collection
This study was approved by the Ethics Review Board of the
Canton of Zürich (KEK-ZH-No. 2011-0253/4) and was conducted
in accordance with the guidelines of the World Medical Associ-
ation Declaration of Helsinki. The participating patients were in
need of root canal treatment, and were treated at the Clinic for
Preventive Dentistry, Periodontology and Cardiology, University
of Zürich, Center of Dental Medicine, Switzerland by one oper-
ator specialized in endodontics (DKR). The patients were asked if
they were willing to participate in the study if they were of full
age ("18 y), and were excluded from the study if they: (i) were
unwilling to participate, (ii) were under long-term medication,
such as immunosuppressive chemotherapy or any antibiotics,
(iii) suffered from systemic illness (i.e. cardiovascular and respi-
ratory disease, diabetes mellitus, HIV infection or hepatitis), or
(iv) were pregnant or in lactation. The clinical condition was
diagnosed according to the patient’s case history, clinical in-
spection, palpation, tenderness to percussion, vitality testing,
probing depth and single-tooth radiographic examination. The
clinical conditions included in the study were irreversible pul-
pitis but normal apical tissues (pulpitis, n ¼ 27), pulp necrotic
teeth with apical periodontitis (N-AP, n ¼ 33), or apical peri-
odontitis associated with a root-ﬁlled tooth (R-AP, n ¼ 21). Only
one tooth per patient was included in the study. None of the
sampled teeth exhibited a conﬁrmed combined endodontic-
periodontal lesion. All patients who entered the study gave
written informed consent. All operative procedures were per-
formed under a dental microscope and rubber dam isolation. The
endodontic access was prepared with a sterile diamond-coated
bur and the root canals were instrumented using ProTaper in-
struments (Maillefer Dentsply, Ballaigues, Switzerland), while
endodontic working length was determined endometrically
(Root ZX mini, J Morita Corp., Tustin, CA) with a hand ﬁle
(Maillefer, Dentsply). The root canals were instrumented up to
their apical constriction, under continuous manual irrigation
with 1% NaOCl. During this process, a size-15 hand ﬁle was also
used, to keep the apical foramen patent. After instrumentation to
ProTaper F2, 5 ml of sterile physiological saline solution were
administered to full working length to inactivate possible rem-
nants of NaOCl. After drying the root canal with sterile paper
points, a ﬁne paper point (Orbis Dental, Münster, Germany) was
inserted approximately 2 mm above the apical foramen to collect
the apical tissue ﬂuid, and the point was kept in that position for
30 s. Three consecutive paper points were collected from one
canal and immediately after frozen at $80 %C until further
processing.
2.2. Sample preparation
Initially, the paper point content was re-eluted in the tubes with
300 ml of sterile phosphate buffered saline (PBS), containing a
protease inhibitor (complete mini EDTA free, Roche, Basel,
Switzerland). The tubes were placed for 5 h on a platform shaker at
(2000 rpm) at 4 %C, vortexed for 30 s, and thereafter centrifuged for
10 min at 5000 rpm. The resulting cell pellet was collected and
processed for analysis, as described further.
2.3. Analysis of apical samples by ﬂuorescent in situ hybridization
(FISH) and epiﬂuorescence microscopy
The detection and counting of bacteria in the prepared samples
was performed by FISH, followed by epiﬂuorescence microscopy, in
similar principles as previously described [8]. Brieﬂy, 50 ml of 0.9%
NaCl containingRNase inhibitor (SigmaAldrich, Buchs, Switzerland)
were added onto the pelleted sample, followed by shaking for
45min, and vortexing for 1min. Then,10 ml of the suspensions were
mixedwith 5 ml of coating buffer (0.9%NaCl, 0.02%NaN3, 2.5&10$4%
hexadecyltrimethylammonium bromide) on multi-well epoxy
coated Adcell slides, with a well-diameter of 4 mm (Cel-Line, Erie
Sientiﬁc Company, Portsmouth, NH, USA). The slides were air-dried
and ﬁxed by a 20 min-incubation in 4% paraformaldehyde at 4 %C,
washedwithnanopureH2Oand thenprocessed for FISH analysis [8].
Every well was covered with 9 ml Denhardt’s Solution (diluted 1:50
in PBS), including 1:500 RNase inhibitor, to reduce non-speciﬁc
probe binding to the bacterial cell wall. The slides were then incu-
bated for 30min at 37 %C. Four speciﬁc oligonucleotide rRNA probes
were used for Synergistetes cluster A and Synergistetes cluster B
bacteria [6,8], a genus-speciﬁc probe for oral Fusobacteria [18], and a
genus-speciﬁc probe for oral Actinomyces [19]. The cluster classiﬁ-
cation of oral Synergistetes bacteria into A and Bwas based on earlier
studies [2,6,8]. Table 1 lists theoligonucleotide sequences andCy3or
6-FAM labeling of the used rRNA probes (Microsynth, Balgach,
Switzerland), as well as their targeted taxa. The ﬁnal probe con-
centrations used for FISHwere 5 ng/ml for Cy3 conjugates and 20 ng/
ml for FAM conjugates, in the presence of 40% formamide. For hy-
bridization, 3e4 ml of probe solution was added to the wells, and
incubated for 4 h, at 46 %C. Thereafter, theywerewashed for 30min,
air-dried and coveredwith 50 ml mounting ﬂuid and a cover-slip. An
Olympus BX60 ﬂuorescence microscope (Olympus Optical AG, Vol-
ketswil, Switzerland)was used for the quantitative evaluation of the
FISH stained samples. Fluorescence and direct light images of the
detected bacteria were taken by an Olympus E510 camera. The
quantitative evaluation of the stained bacterial taxa was done by
counting the ﬂuorescent bacterial cells in at least 10 viewing ﬁelds
per well, at 100& magniﬁcation, as previously described [20]. The
lowest detection limit of the assay was 50 bacterial counts per
sample.
2.4. Statistical analysis
The Chi-square test was used to compare the frequencies of
detection of the different bacterial taxa among the three clinical
diagnosis groups. Statistical signiﬁcance level was set at P < 0.05.
Table 1
16S rRNA-targeted probe sequences for FISH and target taxa.
Probe Sequence (50e30) Target taxa
SYN-A1409-FAM ACACCCGGCTCGGGTGGT Synergistetes cluster A
SYN-B1149-Cy3 TCGATGGCAGTCTCGCCG Synergistetes cluster B
L-ACT476-2-FAM ATCCAGCTACCGTCAACC Genus Actinomyces
FUS664-Cy3 CTTGTAGTTCCGCYTACCTC Genus Fusobacterium
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3. Results
The presence of Synergistetes in the apical samples obtained
from the three different clinical conditions was evaluated using
FISH and epiﬂuorescence microscopy. The frequencies of detection
of the different taxawere ﬁrst calculated (Table 2). It was found that
Synergistetes cluster A bacteria were present 10% of N-AP cases, in
24% of R-AP cases, but none of pulpitis cases. Interestingly, Syn-
ergistetes cluster B was not detectable in any of the groups. To
conﬁrm the presence of well-established endodontic pathogens in
apical periodontitis, the Actinomyces and Fusobacterium genera
were further investigated using 16S rRNA genera-speciﬁc oligo-
nucleotide probes. It was found that Actinomyces were detected in
12% of N-AP cases, 48% of R-AP cases, but none of the pulpitis cases.
On the other hand Fusobacteriawere detected in 12% of N-AP cases,
38% of R-AP cases, and 11% of the pulpitis cases. These differences in
detection proved to be statistically signiﬁcant between clinical
diagnosis groups for all taxa analyzed, with the exception of Syn-
ergistetes cluster B, which was undetectable under the present
conditions. Regarding the numerical levels of detection of the
investigated taxa, these ranged between 50 and 255 counts for
Synergistetes cluster A, 70e1650 counts for Actinomyces, and 50e
720 counts for Fusobacteria (Table 3). The highest bacterial numbers
were detected in samples with clinical diagnosis of R-AP, followed
by N-AP.
The investigated bacterial taxa were further characterized
morphologically, as appeared by FISH staining under epiﬂuor-
escence microscopy. The Synergistetes cluster A bacteria, detected
only in the N-AP and R-AP cases, appeared as long rods, which were
either in straight form (Fig. 1A, B) or curved form (Fig. 1C, D).
Fusobacteria appeared as elongated spindle-shaped rods either as
single cell bodies (Fig. 2AeD) or forming complexes of several
bacterial cells (Fig. 2EeH). Actinomyces appeared as irregularly
shaped long rods (Fig. 3AeD), occasionally forming intertwining
ﬁlamentous structures (Fig. 3E, F).
4. Discussion
In summary, the presence and levels of Synergistetes was eval-
uated in apical samples of teeth diagnosed with N-AP or R-AP. As
clinical control, a pulpitis group was employed, whereas as
microbiological controls, the presence of well-established end-
odontic pathogens (i.e. Fusobacteria and Actinomyces) was evalu-
ated. Sampling from the root canal system is not free from
methodological pitfalls [21]. One problemwith root canal sampling,
as with periodontal sampling, is the fact that microorganisms from
sites other than the front of the lesion are collected along with
counterparts that cause disease progression. In the current study, it
was aimed to sample from the apical aspect of the root canal sys-
tem, and thus, NaOCl was used to lyse the bacteria that may have
been present in the coronal aspects of the root canal. However, as
can be seen by the fact that Fusobacteria could be sampled in 11% of
the irreversible pulpitis cases, which should essentially be bacteria-
free in the apical region [11], we cannot necessarily claim that the
current sampling procedure predictably prevented false-positive
results in the sense that bacteria were transported from the tooth
crown to the apex during root canal preparation prior to sampling.
Nevertheless, the current results clearly show that there is a vast
difference in numbers of recovered taxa between teeth with apical
periodontitis and counterparts with irreversible pulpitis.
Itwas found that Synergistetes cluster A bacteriaweredetected in
both N-AP and R-AP but not in pulpitis. Their prevalence as well as
detection rangewas greater in R-AP compared toN-AP. Synergistetes
cluster B was not detected in any of the three clinical diagnosis
groups, implying that it is not crucial in the establishment of AP, as
has also been demonstrated in the case of marginal periodontal
diseases [6,8]. Earlier works used other molecular assays to detect
Synergistetes in samples obtained from the apical part of N-AP or R-
AP-affected teeth and analyzed by 16S rRNA-based nested or hemi-
nested PCR, or by reverse-capture checkerboard hybridization as-
says. In these studies, the main Synergistetes oral clones detected
included BA121 (now designated as Pyramidobacter piscolens),
BH017/D084, W090 (now designated as Fretibacterium fastidiosum)
and E3_33 (nowdesignated as Jonquetella anthropi), andwere found
at prevalence of up to 33% [16,17,22,23]. Among those, Synergistes
oral clone BA121 (P. piscolens) was the most frequently detected
(29%) [23,24], at levels exceeding 105 DNA counts [25], and was also
among the most frequently detected taxa in endodontic abscesses
[26]. Hence, the prevalence reported in these earlier studies using
PCR-based methods is well in agreement ﬁndings of the present
study for the prevalence of Synergistetes cluster A in N-AP and R-AP
(10% and 24%, respectively). Yet, some of the previously identiﬁed
species (P. piscolens and J. anthropi) belong to Synergistetes cluster B,
while the present study failed to detect bacteria in this cluster. The
possible explanation for this discrepancy is that the cluster B species
described to date are smaller in size than cluster A taxa, so theymay
be harder to detect by FISH. Moreover, the 16S rRNA probe used in
the present studywas designed for a broad range of cluster B clones,
and not exclusively for these two species [8]. This study additionally
demonstrates the morphology of Synergistetes cluster A in apical
samples, and conﬁrms the absence of any Synergistetes in pulpitis.
The structure of Synergistetes cluster A described here by FISH, re-
sembles that of Synergistetes identiﬁed in dental plaque of gingivitis
patients, using the same method [8].
Bacteria of the genus Actinomyces are highly prevalent in the
polymicrobial communities of infected dental root canals [27], and
account for themajority of Gram-positive rods identiﬁed in AP [28].
Their persistence in the root canal is associated with failed end-
odontic treatment and incomplete periapical healing, as identiﬁed
by bacterial cultivation [29], or by PCR-based methods [30]. The
high prevalence of Actinomyces and Fusobacteria in the apical re-
gion of teethwith endodontic infection has also been demonstrated
by pyrosequencing analysis, which revealed great diversity in the
bacterial communities of the affected teeth, as well as a great inter-
individual diversity [31]. Accordingly, when the bacterial commu-
nities of the apical portion of N-AP or R-AP-affected teeth were
compared, a high prevalence of Fusobacteria and Actinomyces was
conﬁrmed, with R-AP displaying a greater diversity in bacterial
composition [32]. Peri-radicular lesion samples analyzed by a 454-
sequencing platform revealed that among the most abundant
genera, as represented by the total yield of sequences, were Fuso-
bacterium and Actinomyces [33]. In the present study, Actinomyces
Table 2
Frequency of detection of different taxa in apical samples per clinical diagnosis.
Pulpitis N-AP R-AP P Value
Synergistetes cluster A 0/27 (0%) 3/33 (10%) 5/21 (24%) 0.022
Synergistetes cluster B 0/27 (0%) 0/33 (0%) 0/21 (0%) N/A
Actinomyces 0/27 (0%) 4/33 (12%) 10/21 (48%) <0.0001
Fusobacteria 3/27 (11%) 4/33 (12%) 8/21 (38%) 0.027
Table 3
Range of detection (bacterial counts) of different taxa in the apical samples per
clinical diagnosis.
Pulpitis N-AP R-AP
Synergistetes cluster A Not detected 50e90 70e255
Synergistetes cluster B Not detected Not detected Not detected
Actinomyces Not detected 70e600 55e1650
Fusobacteria 50e105 70e135 50e720
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Fig. 1. Morphology of bacteria from Synergistetes cluster A in apical samples, as identiﬁed by FISH. (A and C) Phase contrast and (B and D) corresponding epiﬂuorescence images
stained with SYN-A1409-FAM probe. Scale bar ¼ 5 mm.
Fig. 2. Morphology of Fusobacteria in apical samples, as identiﬁed by FISH. (A, C, E, and G) Phase contrast and (B, D, F and H) corresponding epiﬂuorescence images stained with
FUS664-Cy3 probe. Scale bar ¼ 5 mm.
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and Fusobacteria were detected in both N-AP and R-AP, albeit at
higher prevalence and numeric range in the latter case. These
ﬁndings are well in line with the literature. The novelty of the
present study is the conﬁrmation of the presence of Actinomyces
and Fusobacteria in periapical pathoses by FISH staining and
microscopic visualization. With the help of the selected probes
used, the bacteria could be identiﬁed the genus level, but not the
phylotype level. The fact that these bacteria have been micro-
scopically identiﬁed here proves their apical presence by culture-
independent methods. However, this does not necessarily imply
that they would be retrievable by cultivation, as their density was
relatively low. Still, the method provides the possibility for
descriptive information on the morphology of the microorganisms
under investigation. Indirect immunoﬂuorescence microscopy has
been used earlier to determine the presence of selected Actino-
myces species in endodontic infections. These were identiﬁed in
60% of the cases [34], which is proximal to the 48% prevalence in R-
AP, reported in this study.
In conclusion, the ﬁndings of this study represent a snapshot of
the microbial complexity in the apical root canal region. The FISH
method employed here allows for the visual identiﬁcation and
relative enumeration of the targeted taxa, irrespective of their
cultivability. The physical presence of Synergistetes cluster A bac-
teria was conﬁrmed in both N-AP and R-AP, whereas this was ab-
sent in pulpitis. A stronger presence of this cluster was evident in R-
AP, while cluster B was non-detectable in any of clinical diagnosis
groups. In conclusion, Synergistetes cluster A, but not cluster B,
bacteria can be found intact as part of the mixed apical microbiota
of AP infections, and may be involved in their pathogenesis.
Whether this association represents a causal relationship with the
disease, or is merely a result of opportunistic infection remains to
be elucidated.
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Recent systematic reviews have substantiated the fact that current testing methods to assess the inflammatory
state of the pulp and the periapical tissues are of limited value. Consequently, it may be time to search for
alternative routes in endodontic diagnostics. Molecular assessment methods could be the future. However, in
the field of endodontics, the research in that direction is only about to evolve. Because pulpal and periradicular
diseases are related to opportunistic infections, diagnostics can either target microorganisms or the host
reaction. This communication discusses clinical situations in which a molecular assessment of infection or host
reaction could be of interest. The methods, collection sites, current state of research, and unresolved problems
are evaluated.
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Introduction
The term “diagnosis” stems from the ancient Greek
concept of relating a disease to a tangible cause
rather than to the will of a higher power. Translated
into English, diagnosis, from δια and γνω´ση, means
“thorough understanding,” or understanding the
cause–effect relationship in a specific disease. In
clinical endodontics, the cause of disease is
opportunistic infection of dental hard tissues by oral
or transient microorganisms (1,2). If these infections
are removed, the dental pulp and periapical tissues
have a high propensity to heal (3,4). Consequently,
endodontic diagnostics should focus on either the
extent of the microbial infection or the inflammatory
reaction of the host tissue. Strangely enough, current
methods do neither (5,6). Instead, pulp tests are
based on triggering a nerve response, while periapical
diagnostics rely on radiographic imaging. These
methods have their clear benefits in everyday clinical
practice, but also their limitations, which have been
discussed elsewhere (5–7) and shall not be detailed in
the current communication. Methods concentrating
on pulpal blood flow are also beyond the scope of
this communication and not discussed. Laser
Doppler flowmetry (8), pulp oxyometry (9), and
dual-wavelength spectrophotometry (10) can be
useful in coronally intact front teeth after trauma (6).
However, the application of those methods is limited
by their inability to monitor teeth with restorations
and lateral teeth. Therefore it is unlikely that they
will gain much relevance in restorative dentistry and
endodontics.
The great majority of papers on pulp diagnosis
have focused on the question: is the pulp
histologically or clinically vital or necrotic? Based on
this dichotomized outcome, the sensitivity and
specificity of a test can be calculated. In clinical
practice, however, other questions are asked, such as:
“will the pulp survive after I place a permanent
restoration?” or “will the periapical inflammation
recede after root canal treatment has been initiated?”
These questions are not addressed at all with current
diagnostic tools.
This paper will focus on the possibility of
diagnosing pulpal and periapical inflammation via
molecular markers. As is discussed in the following
text, this approach could reveal information from a
spatially restricted area, which may help to save vital
tissues.
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A brief take on the status quo of
endodontic diagnostics
Monitoring pulpal health
The history of a tooth can have a great impact on the
treatment decision. However, in the context of correct
diagnosis of the state of the pulp, this information can
only contribute to, but not tell, the overall picture. It
has been shown that whether or not a tooth has a
history of pain does not necessarily reveal much about
its condition (11,12). Monitoring pulpal health is
therefore recommended during routine dental visits
and after operative procedures aimed at maintaining
pulpal vitality. The most common method is the cold
test, using either a carbon dioxide pencil or a cotton
pellet saturated with refrigerant spray (1,1,1,2-
tetrafluoroethane). The application of cold to tooth
crowns stimulates vital, thermo-sensitive nerve fibers.
In the case of a sensitive pulp, the patient perceives
pain. Further methods are the application of heat,
electric currents (electric pulp test), or even test
drilling through present restorations. However, the
validity of such tests is frequently limited in teeth with
coronal restorations, with pulp canal obliteration, or
after trauma. The advantages and disadvantages of the
respective methods are discussed in detail elsewhere
(5–7,13). Nevertheless, it is worth mentioning that all
of the common pulp tests solely rely on the patient’s
subjective response to a stimulus. Depending on
several factors such as anxiety, cultural background,
level of analgesia by painkillers, or the patient’s mood,
this stimulus can be perceived differently. Because
current pulp tests are not able to identify the state of
the pulp, they should be called “sensitivity tests”
rather than “vitality tests.”
Monitoring periapical health
Teeth with a negative sensitivity test are checked
radiographically to identify the presence or absence of
apical periodontitis. The presence of a periapical
radiolucency is correlated with pulpal necrosis and
histological signs of inflammation at the periapex (14).
However, intact tissues including nerve fibers have
been observed histologically in the pulp stump of the
apical root third, despite the presence of an apparent
periapical lesion (15). Moreover, on periapical
radiographs, it can take up to 1 year to see a decisive
change in the appearance of the periapex (16). A
further problem with two-dimensional imaging is
anatomical blurring (17,18). Apical periodontitis in
cancellous bone, for example, can be non-detectable
radiographically, even though extensive disease is
present (17,18). In theory, three-dimensional imaging
may overcome this problem (19). However, radiation
to oral tissues with current methods is still
not acceptable for standard monitoring (20).
Furthermore, while such data exist for conventional
radiographs (14,21), the correlation between the
histology of periapical tissues and their radiographic
appearance has not been established in three-
dimensional images. As an example, it is not known
what scar healing would look like on cone-beam
images (22). Moreover, as shown most recently,
healthy teeth can have a widened ligament in cone-
beam images (23).
Pulpal and periapical inflammation
In the context of diagnostics, it would appear to be of
utmost importance to understand the inflammatory
diseases that we treat or try to prevent in everyday
clinical practice. Our focus should especially be on the
location of the inflammation for a given condition
(Fig. 1).
Pulpal inflammation, in the vast majority of cases, is
triggered by microorganisms. These enter the pulp
space either through caries (15), traumatic fractures or
cracks in the dentin (24), or, in the absence of a
functioning pulp, exposed dentinal tubules (25). The
oral microbiota interacts with the hard tissues of the
tooth crown. This is also why the infectious process
initiates in the crown or the cervical area of the tooth.
As the infection progresses from the coronal to the
apical aspects of the root canal system, a radiographic
lesion around the portals of exit of the root canal
system becomes apparent. The radiographic lesion
reflects the advancing periapical bone resorption,
which is part of the host response to the presence of
microorganisms in the root canal (26). As the disease
process continues, biofilm formation occurs all the way
into the complex anatomy of the root apex (27), which
can be extremely difficult to debride and disinfect
(28,29). This may be seen as the biological reason why
the presence or absence of a periapical lesion prior to
intervention is the main predictor for the radiological
outcome of root canal treatment (30,31).
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From the aspect of preventive dentistry, it should be
clear that hindering the progression of pulpal infection
should be the aim. Conceptually, as Paracelsus knew
500 years ago: “If you prevent infection, Nature will
heal the wound by herself” (32). At the same time,
vital, non-infected tissues should be preserved.
Primum non nocere (Scribonius Largus, approximately
50 AD) has remained a core ethical principle in
medicine (33). This is currently not done, or at least
not consequently practiced in everyday clinics. As will
be discussed below, the lack of proper diagnostic
methods plays a major role in this context. Or in other
words: as long as we do not know what we treat,
overtreatment seems to be easier and more predictable
than preservation of vital tissues. As an example, if we
attempt to maintain vitality in a pulp, which is, in
reality, irreversibly inflamed, the patient may
experience excruciating pain in the future (Fig. 1, top
right). In a retrospective study on the survival of pulps
after direct pulp capping procedures in teeth with a
normal response to the cold test, a mere 20% of the
pulps remained vital after 10 years (34). This also
suggests that at least 50% of the teeth that lost pulpal
vitality during the observation period should have
caused some form of memorable discomfort to the
patient (12).
Treatment concepts: from the
crown to the apex and back again
Maintaining coronal pulp vitality
Infection of the dentin–pulp continuum usually
initiates in the coronal aspect of the tooth and
progresses apically. The main reason is caries, which
will be discussed in some detail. However, cracks in the
dentin should not be left unmentioned, as they can be
the hidden cause of irreversible pulpitis and its typical
clinical symptoms (35). Regardless of the route of
microbial challenge to the pulp, it is not quite clear
when an actual intervention into the pulp is necessary
and when it is not. In caries that does not reach into
the inner 1⁄3 of the dentin, complete excavation is not
mandatory. A tight coronal seal is apparently sufficient
to arrest the process (36). The same may be true for
caries that reaches into the inner 1⁄3 on the preoperative
radiograph. At least in the short term, stepwise
excavation has consistently performed better than full
excavation in terms of maintaining pulp vitality (37–
39). However, patients experiencing spontaneous pain
prior to treatment were excluded from these studies. If
pain is taken as an outcome, there was no difference
between stepwise excavation and direct pulp capping.
In the most detailed and scientifically sound
randomized trial on the topic of complete versus
partial excavation to date (39), 8 of the 143 patients in
the stepwise excavation group experienced unbearable
pain leading to pulpectomy within the first year after
treatment, compared to 7 of the 149 patients in the
complete excavation group (P = 0.93). Long-term
follow-up studies exist only for direct pulp capping.
These show a consistent yearly failure rate,
culminating in maintained pulpal vitality as low as 20%
after 10 years (34).
Fig. 1. Schematic depiction of different histiological
states of the pulp and the periapex that can be
encountered with similar results obtained by current
diagnostic tests. Bacterial invasion is represented in
green; inflammatory infiltrate in red. With a positive
pulp test, in the absence of radiolucency, the pulp may
already be infected and thus irreversibly inflamed, at
least in its coronal aspect (top right). However, with a
negative pulp test and an apical radiolucency, parts of the
pulp tissue may still be vital and not necessarily
infiltrated with inflammatory cells (bottom left). This
diagram should highlight the need for better, site-
specific diagnostics that can reveal the state of the pulp
and/or the periapex.
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Another, often overlooked, reason for losing pulpal
vitality is devitalization through the preparation of
teeth for indirect fixed reconstructions. Systematic
reviews have suggested that roughly 10% of abutment
teeth pulps become necrotic within 10 years after
restoration (40). However, the true number may be
higher, as these reviews included studies that did not
specifically focus on the assessment of pulp vitality.
Cheung and co-workers followed 199 initially vital
abutment teeth for a mean of 15 years (41). Of these
teeth, 77 were bridge abutments while 122 were
restored with single metal-ceramic crowns. Of the
bridge abutments, 32.5% became necrotic during
the observation period, compared to 15.6% of the
crowned teeth (P < 0.05). This is in line with the
classic study on teeth with advanced periodontal
disease that were included in long-span bridges (42).
Of the abutment teeth, 15% developed pulpal necrosis
over 9 years, compared to 3% of the teeth that were
not included in the reconstructions.
Pulpotomy versus pulpectomy
In current clinical practice, the treatment of teeth with
necrotic, partially vital, and vital pulps is the same: full
pulpectomy. The designated treatment goal of
pulpectomy is the removal of all organic substrate from
the root canal system (43). However, this is not based
on any biological or clinical fact (44) but rather on
radiological esthetics. Earlier authors realized that
dentin chips obtained from instrumenting non-
infected root canals are the perfect biomaterial to seal
off root canals (45,46). The preparation goal in many
schools was to instrument 3 mm short of the apical
foramen in vital cases, to maintain a vital pulp stump in
the apical root canal system (47). But this concept
has not stood the test of time. The reason for
instrumenting to full working length is probably two-
fold: the endodontist can show his or her skills on the
radiograph, which can then also be appreciated at
recall by another dentist, who may not know whether
a tooth contained a vital pulp prior to treatment or had
apical periodontitis. The second reason is that during
endodontic treatment it is currently not possible to
know whether the remaining tissue is free of bacterial
infection or not. Conversely, it may be so that in most
vital teeth with irreversible pulpitis, it is unnecessary to
instrument and fill the root at all. Complete
pulpotomy, i.e. the removal of the coronal pulp
without entering the root canals, in combination with
a tight coronal seal, could become a valid treatment in
cases of irreversible pulpits (48). Some randomized
trials have pointed in that direction (49,50).
Unfortunately, the authors of these articles submitted
the same data to different journals simultaneously.
Their articles on pulpotomy versus pulpectomy were
removed from the Journal of Dental Research and the
Journal of Endodontics. Consequently, we have to
wait for results from other groups to validate these
potentially important data.
Pulp tissue engineering
Tissue regeneration strategies have gained substantial
attention in the dental literature in recent years (51).
Amongst the regenerative dental procedures,
revascularization of a necrotic pulp space appears to be
the treatment option that holds the most promise for
the immediate future (52). The idea of revascularizing
a necrotic pulp space in order to induce continued
root formation is not new. In fact, it is a common
procedure in dental traumatology (53). The first
report to describe this procedure in teeth affected by
caries and its sequelae dates back half a century (54).
However, a subsequent study from that time in vital
and non-vital human teeth of adult patients showed
that revascularization was only possible in teeth that
had contained a vital pulp prior to treatment (55). The
tooth revascularization concept disappeared for three
decades, only to resurge some years ago in the form of
case reports (56). The so-called revascularization
procedure is deemed to be especially helpful in
children with teeth with incomplete root formation. In
the first visit, the root canal system is disinfected by
irrigation with a sodium hypochlorite solution and the
placement of an antibiotic paste. In a following visit,
the paste needs to be removed, and after inducing
bleeding from the apical tissues, the blood clot in the
coronal aspect of the root canal is sealed off using a
calcium-silicate cement covered by a permanent
restorative material (57). Ideally this procedure results
in continued root development in length and width.
However, recent observations question whether new
dentin formation really occurs. What probably
happens is that, once the infection is treated,
periodontal tissues grow into the pulp space of the
immature root with the open apex (58). Recent
advances in tissue engineering and cell homing could
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make it possible to extend this concept to adult teeth
that contain some vital pulp tissue (59).
Why could molecular diagnostics
be helpful?
It would be good if a patient’s subjective response to
traditional pulp sensitivity tests could be overcome.
Furthermore, diagnostic methods should be more
site-specific and accurate than the tests we currently
have. This would enable the avoidance of
overtreatment and the maintenance of vital tissues.
Such methods could help to delineate the level of
instrumentation necessary in a given clinical situation.
In restorative dentistry, this could help to determine
whether a pulp requires any kind of treatment prior to
restoration or not. This would be important for direct
or indirect pulp capping procedures as well as for the
assessment of the general pulpal health before the
replacement of fillings or indirect restorations. In
terms of the root canal treatment itself, it would be
good to know whether a pulp can be kept in its
entirety, or, if pulpotomy or amputation of the pulp is
intended, at which level this procedure should be
executed. Furthermore, if pulpectomy is performed in
teeth with apical periodontitis, it would be helpful to
know whether the inflammation in the periapex is
about to heal prior to obturation of the root canal
system.
For all of the above tasks, molecular analysis of the
site of intervention could be of diagnostic value. As we
deal with opportunistic infections, the first question
that arises in this context is whether it would be
preferable to identify and/or analyze molecules that
reflect bacterial presence or the inflammatory state of
the involved tissues.
Bacteria or host response?
Targeting bacteria allows for a direct assessment of the
cause of disease. Historically, the root canal content
was cultured either to confirm the reduction or
absence of bacteria prior to obturation, or to define
the individual bacterial composition of the infection.
The latter was done to generate an antibiogram on
which the clinician was supposed to choose the
suitable antibiotic for the therapy (60). However,
endodontic infections have been shown to be
non-specific and composed of mixed microorganisms
(61). They are driven by ecological factors rather than
specificities of the invading species, and thus the
concept of the “ecological plaque hypothesis” (62)
should not only be extended to periodontal but also to
endodontic infections (63). Taken together, those
circumstances make it rather unlikely that it might be
possible to identify an individual key microorganism,
or even a specific group of microorganisms, of superior
diagnostic value. The elusiveness of site-specific
microorganisms, which are routinely present at the
forefront of endodontic infections but absent from
other oral sites, renders root canal sampling for
diagnostic purposes error-prone. Culture methods,
once mandatory for dental students, have been
questioned and abandoned for routine root canal
treatments (44). In addition, there are methodological
pitfalls associated with culturing microorganisms from
root canals (64). Contamination is always a problem.
Meticulous precautions need to be applied in order to
avoid false positive results when microbial samples are
collected from root canals for research purposes
(65,66).
As a more straight-forward alternative to culturing,
it may be possible to identify sessile bacterial
aggregates directly by simple optical methods (Fig. 2).
It has been shown that bacterial colonies can be
excited with filtered xenon light (405 ± 20 nm) and
viewed through a 530-nm high-pass filter (67). This
approach is used in cariology for conservative caries
excavation (68). There is now a commercially available
system on the market called FACE (fluorescence-aided
caries excavation, Sirona, Bensheim, Germany).
Effectively, FACE does not trace bacteria, but rather
porphyrine compounds in dentin associated with
microbial presence (69). Theoretically, this method
could be useful in vital pulp therapy. After a pulpotomy
procedure, it could be used to assess whether the
remaining tissue or the root canal dentin is infected
or not. However, it is currently unknown whether
fluorescence methods are suitable for tracking pulpal
infection. Studies should be performed to determine
this.
In the context of molecular diagnostics, there are
some clear advantages to assessing the host response
rather than bacterial invasion. That is probably why
there have been more approaches in that direction.
Each site and tissue fluid has its specific environment
of host factors (70–72). This fact, per se, can
Molecular diagnostics in endodontics
55
circumvent the problem of contamination with e.g
saliva. The composition of the respective analyte is
altered during an inflammatory process. Therefore
factors associated with disease can be associated or
controlled against counterparts associated with
health.
Which fluid to collect?
Depending on the given clinical situation, the
intervention may aim to maintain pulpal vitality or
regain periapical health. Logic would dictate that
different clinical situations need to be approached with
different tests. Biologically, the main target should be
to locate the bacterial invasion in the continuum of the
pulp space and the periapex (Fig. 1). The following
text will discuss sampling fluids and sites.
Gingival crevicular fluid (GCF)
GCF is an exudate that derives from the gingival
crevice. It contains a multitude of host factors
including antibodies, bacterial antigens, proteins, and
cytokines (73). In the late 1950s the idea was born to
correlate molecular markers of GCF with periodontal
inflammation, because GCF is produced and modified
by the periodontal ligament (74). Since then many
studies have shown that host factors are differentially
present in the GCF of periodontally affected teeth
compared to healthy counterparts (75). The same
has been shown for orthodontically induced root
resorption (76) and trauma-induced root resorption
(77). All of those observations share the feature that
periodontal inflammation is assessed, regardless
of the underlying cause. This is possible because the
neural and vascular supplies of the periodontium
and endodontium are functionally and anatomically
connected (78,79). Since collecting GCF is a non-
invasive procedure, it might thus provide diagnostic
information for any given clinical situation. However,
studies investigating changes of host factors in
GCF of endontically involved teeth are relatively
sparse. Some studies showed that the composition of
neurotransmitters, interleukin-8, or MMP-8 differs in
GCF from painful versus non-painful teeth (80–83).
Other investigations evaluated the differences in the
molecular composition of GCF between teeth with
asymptomatic apical periodontitis compared to non-
diseased controls (84–86).
GCF analyses are deemed to be promising by some
researchers because apical periodontitis, similar to
marginal periodontitis, is a local inflammation of the
periodontal ligament. Indeed, in theory it might
even be possible to assess the dynamics of apical
periodontitis (e.g. healing of apical periodontitis after
root canal treatment) using GCF. However, one
major drawback in the evaluation of host mediators
in GCF is that tissue inflammation, independent of
its cause, is a non-specific process of the innate
immunity (87). This renders it difficult, if not
impossible, to distinguish on a molecular level
between a marginal and an apical periodontal
inflammation. Thus, there will always be bias from
gingival or periodontal inflammation in GCF analyses
targeted at pulpal or periapical disease. Furthermore,
the GCF is unlikely to be able to reflect the spatial
level of microbial progress in the pulp space, which,
as delineated above, should dictate treatment
decisions. The gingival crevice is thus probably not
the most ideal collection site for molecular
diagnostics in endodontics.
Fig. 2. Longitudinal section of a molar affected by
caries excited with violet light (370–420 nm) and
observed through a 530-nm high-pass filter (A). This
method is applied clinically in a system known as
FACE (fluorescence-aided caries excavation). A clinical
picture (B) shows a premolar before complete caries
excavation. The method highlights porphyrin rings,
which are abundant in the presence of certain bacteria.
This can be appreciated by directly monitoring
bacterial colonies: Prevotella intermedia growing on
blood agar depicted using the FACE method (C).
These images are courtesy of Prof. Wolfgang Buchalla,
Regensburg, Germany.
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Pulpal blood
Blood and its cellular components play an essential
role in the specific and the non-specific immune
system. Hemogram analyses are a standard of care
in general medical practice and enable us to draw
conclusions on a variety of conditions with an effect on
blood composition. Blood from the pulp can carry
factors that differ from those in the peripheral blood
(88), indicating that there is site-specific information
to be gained from this fluid.
The first person to investigate a pulpal blood
hemogram was Dr. Florian Prader at the University of
Zürich (70). In 1949 he compared pulpal blood
smears of teeth with advancing endodontic infection
to their inflammatory status assessed by histology
and concluded that progressing bacterial involvement
is associated with a quantitative elevation of
cellular blood compounds, most prominently
polymorphonuclear neutrophil granulocytes (PMNs).
About fifteen years later, Guthrie and co-workers
published their classic study on pulpal blood
examination (89). They compared clinical signs and
symptoms of endodontically involved teeth with
pulpal blood smears and the histological status of
those same teeth after extraction. The authors made
two main observations, which are worthy of being
repeated word-for-word:
(i) “The fact that a high percentage of the pulps in
the poor risk group bled profusely from the
exposed site upon removal of the caries, gave
limited support to the belief that excessive
hemorrhage from an exposed pulp is one
contraindication for vital pulp therapy.”
(ii) “It was interesting to note that none of the
teeth which exhibited high neutrophil counts
were found to be in the good risk group
(histologically).”
This study highlighted again the pivotal role of PMNs
in the breakdown of the pulp.
Since the Guthrie study, only two studies have
used modern molecular techniques (enzyme-linked
immunosorbent assay, ELISA) to evaluate human
pulpal blood with respect to molecular markers at the
protein level (90,91). Nakanishi and co-workers
looked at upstream markers in the inflammatory
cascade, and found that IgG, IgA, IgM, elastase, and
especially prostaglandin E2, but not IL-1 or IL-6,
were elevated in inflamed compared to healthy teeth.
A recent study found that the neutrophil-attracting
chemokine IL-8 was significantly elevated in
symptomatic pulpitis teeth compared to clinically
healthy counterparts and teeth with mere caries
exposure of the pulp (91).
One reason that this field of research did not gain
much attention in the past may be that sampling pulpal
blood requires entering the pulp space. It has been
shown that entering the pulp space decreases the
chance that the pulp will survive (39). Nevertheless,
current scientific inventions aimed at pulpal
revascularization or regeneration have in common
that the pulp space is accessed. In such situations,
molecular diagnosis of pulpal blood might provide
valuable information on the condition of the pulp.
There may be an impasse though, and that is the fact
that blood interferes with most protein assays (92,93).
Dentinal fluid
Dentinal fluid is the extracellular fluid that is contained
within dentinal tubules (94). The idea to sample
dentinal fluid from the dentin wound to assess the
state of the pulp stems from the research group of
Professor Pashley (95). It was suggested to assess
factors associated with PMNs, which makes a lot of
sense, as was already noted by Guthrie and co-workers
(89), and will be discussed later in this text. The
Pashley group performed a multitude of studies on
fluid flow through dentin in dog teeth. The first study
on protein levels in dentinal fluid in human teeth
collected in situ was performed by Knutsson and
co-workers (96). These authors filled buccal cavities
with saline solution and collected the content of the
cavity 15 min after application to analyze serum
albumin levels. This is clinically not practical and
highlights the main problem with dentinal fluid
collection: low yields of protein. In in vitro studies this
problem may be overcome by collecting the entire
fluid content of an extracted tooth by occlusal
trimming and centrifugation (97). However, this is
not possible in studies on vital teeth, and thus samples
have been pooled from multiple teeth (98). This
approach, for obvious reasons, cannot be taken in
diagnostics.
In a relatively recent study on dentinal fluid analysis
in clinically healthy and highly painful teeth affected
by the clinical signs of irreversible pulpitis, folded
polyvinylidene difluoride (PVDF) membranes were
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used to collect dentinal fluid from exposed dentin. The
dentin wound was dried by pressured air prior to
collection (99). MMP-9 was identified by a highly
sensitive assay in 7 of the 16 teeth diagnosed with
irreversible pulpitis, compared to zero MMP-9-
positive samples from the 12 healthy control teeth.
The inconsistent recovery of MMP-9 in the clearly
symptomatic pulpitis teeth was related to low yields
and the possible inability of the PVDF membrane to
absorb the fluid from the tubules. As has been shown
in the context of GCF collection and analysis, the type
of vehicle that is used has a great impact on protein
absorption and release (100). Consequently, the
authors performed a study to compare different
vehicles for possible dentinal fluid collection in vitro
and in vivo (101). It was found that large-pore
cellulose membranes yielded more of a molecule
of diagnostic value (MMP-2) compared to PVDF
counterparts. However, more research is necessary to
assess whether or not dentinal fluid analysis could ever
become clinically feasible and meaningful.
It is certainly true that, if procedural problems can
be resolved, dentinal fluid diagnostics would be most
helpful in all of the dental interventions that aim to
maintain a healthy coronal pulp. Dentinal fluid analysis
could shine some light on the clinically unresolved
questions of whether or not a pulp has a chance to
survive indirect pulp capping or the mere preparation
of the tooth as an abutment for an indirect restoration.
Periapical fluid
The term “periapical fluid” or “periapical tissue fluid”
refers to the extracellular fluid present in the periapical
area. If the periapical tissues become inflamed, the
periapical fluid becomes an exudate and its
composition is modified (102). There are different
sub-types of exudates. In the case of severe
inflammation, for example, an exudate can become
purulent and contains dead cell fragments (e.g. from
PMNs). Because exudate formation is an immediate
host reaction, analysis of the exudate may provide
useful information about the current state of
inflammation. Collecting periapical fluid during root
canal treatment is feasible after full pulpectomy.
Ascending periapical fluid has been collected either by
inserting a paper point or a methylcellulose strip to
working length, or by aspiration with a syringe
(72,103,104). Studies on the apical root anatomy of
permanent human teeth have shown that the diameter
of the apical constriction is usually ≥ ISO size 20
(105). Therefore, it is even possible to protrude a
small-sized paper point slightly beyond the apical
constriction to collect the tissue fluid present there
(106).
One outstanding feature of analyzing periapical fluid
is that it enables researchers to study the inflammatory
response to a microbial infection in a closed
environment in humans (107). The background noise
of mediators not induced by the immediate disease
process, a common problem with GCF analysis, is not
present. Bacteria-related factors such as endotoxin
and host-related factors such as cytokines,
immunoglobulins, and MMPs have been identified
from periapical exudates in human root canals
(72,108–110). The concentrations or ratios of some
factors in periapical fluid have been shown to correlate
with clinical signs and symptoms (111–113), the
presence of purulent exudate (102,114), or the size of
the preoperative apical radiolucency (104,108,115).
Furthermore, a relationship between root canal
treatment and the decrease of certain factors has been
established (102–104,110). Overall, those studies
suggest that periapical fluid can be analyzed for
molecular markers and that their concentration can
change under different clinical conditions.
Periapical fluid could be especially helpful in
monitoring the early signs of healing in a two-visit
treatment approach (110,114,116,117). In contrast
to the slow recession of periapical radiolucencies, the
change in molecular composition of periapical fluid
appears to occur quickly, and thus a chairside assay
could be helpful in deciding at the beginning of the
second endodontic visit whether a root canal system
can be filled or requires more thorough disinfection.
Which target molecules should
be considered?
Pulpitis and apical periodontitis are caused by mixed
opportunistic infections. The host response to these is
collectively termed the innate or non-specific immune
system. Histological studies clearly show that pulpitis
is a PMN-driven inflammation (15,118). In fact, the
PMNs form a wall of defense against the microbial
invaders (26). PMNs produce an entire array of
proteolytic enzymes (119,120). These digest soft
tissue and make it possible for the PMNs to infiltrate
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the site of bacterial invasion. However, the innate
defense mechanism also has its limits. If the microbial
invaders are not removed from the tooth, abscess
formation ensues (121) and the pulp tissue necrotizes.
In the context of disease progression, this means that
the host gradually loses its access to the site of
microbial presence (Fig. 3). In the periapical tissues,
the situation is slightly more complex because bone
resorption occurs concomitantly to the recruitment of
the inflammatory infiltrate (107). Nevertheless, the
basics of the immune response remain similar in the
pulp space and the periapical area.
Studies on entire pulp tissue consistently showed
that PMN-related enzymes such as elastase and
cathepsin G (122,123) and MMP-9 (124) are elevated
in clinically inflamed pulps compared to healthy dental
pulps. Histologically, the presence of these enzymes or
their respective mRNAs is strongly correlated to the
inflammatory infiltrate (125,126). The same is true for
IL-8, the main neutrophil chemoattractant. At the
gene expression level, IL-8 levels are distinctly
different between clinically healthy and inflamed
human dental pulps, while upstream genes encoding
for early inflammatory responses such as IL-1β do
not differ between these clinical states (127). IL-8
expression is also spatially correlated with the
inflammatory infiltrate (128).
When it comes to monitoring periapical health, the
picture is less clear (107). This is probably because
some studies aimed at identifying factors associated
with apical periodontitis investigated chronic lesions
undergoing apical surgery rather than progressive
(acute) lesions (129). These lesions could effectively
represent relatively healthy tissue with little propensity
to ever become acute (130).
Based on these biological givens, it makes most sense
to monitor PMN-related factors in molecular
diagnostics. Less site-specific, upstream inflammatory
markers such as IL-1β are not suitable as markers for
pulpitis (90,127), and probably also not for apical
periodontitis. Most interestingly, in all of the studies
that have been performed thus far comparing clinically
healthy and diseased teeth by assessing PMN-related
markers in GCF, pulpal blood, dentinal fluid, or
periapical fluid, a significant difference was found
between the two states (Table 1). PMN factors could
thus also be key in identifying an ongoing
inflammatory process in the periapex (110). A recent
study by the authors showed the absence of IL-8 at the
protein level in the periapical fluid of teeth with
irreversible pulpitis, in contrast to counterparts with
apical periodontitis (131). Alternatively, factors
associated with bone resorption could be targeted, but
these appear to provide less unequivocal results (132).
As clinicians, perhaps unknowingly, we already take
PMN activity into account when treating teeth with
apical periodontitis and a fistula. If the fistula
disappears after the first visit, we know that healing has
initiated. If the fistula is still there at the second visit,
we know that we need to improve our root canal
disinfection protocol and/or consider the rarer
possibility of a self-sustaining extraradicular infection
(133).
Chairside assays: will they ever
be possible?
In dentistry, few sophisticated diagnostic tests have
ever made it to the market. The main reason for this is
probably that the cost and time for these assays do not
justify their application. Nevertheless, it is interesting
to note that in periodontology, molecular testing
methods have found their way into clinics (134), even
though potential overtreatment by the dental
hygienist is cheaper than most of the tests that are
currently on the market, with little or no side-effects
for the patient. In endodontology, all of the
procedures are usually performed by a specialized
Fig. 3. Microscopic view of a histological specimen from
a mandibular molar affected by caries. Note the heavy
infiltration of the pulp tissue with polymorphonuclear
neutrophil granulocytes (PMNs), leading to abscess
formation and pulp necrosis. Courtesy of Prof. Emeritus
Hans-Ueli Luder, University of Zürich.
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dentist and are therefore expensive. Furthermore,
poor treatment decisions may cause severe pain to the
patient. Consequently, it would make sense to develop
better diagnostic tests not only from a health
perspective but also from a socio-economic point of
view. Ideally, these tests should be performed chairside
because it makes little sense to recall a patient just
because we have to wait for a test result from the lab.
The host factors discussed in this communication
can, in theory, be assessed at three levels: gene
expression (mRNA), protein, and active protein.
Assays targeting the gene expression level are unlikely
to ever be applicable in a chairside set-up. The one
GCF assay that is on the market to measure soft tissue
breakdown in periodontal pockets targets active
MMP-8 and thus PMN activity (135,136). This assay
is based on the immunochromatography principle,
which uses two monoclonal antibodies specific for
different epitopes of MMP-8. The assay is essentially
similar to a common pregnancy test, just with a
different target molecule. It has been sold under
various brand names such as PerioSafe and
Periomarker by different companies such as
Dentognostics, Hager und Werken GmbH, and
GlaxoSmithKline Consumer Healthcare. The priority
date for the underlying patent (WO1996007103 A1),
filed by Professor Timo Sorsa, was August 26, 1994.
The patent will thus expire this year. It would be most
interesting to evaluate whether such assays could also
be developed for the analysis of dentinal and periapical
fluid. With the former, there will most likely be a
sensitivity problem as the target proteins collected
from dentinal fluid are in the low ng range (101).
However, with periapical fluid, yields are similar to
GCF and assays could easily be developed.
Concluding remarks
In summary, we can state that much research is
necessary to advance molecular diagnostics in
endodontology. However, it would appear that it is
worth the effort. This communication was composed
to summarize information that is not normally
presented in this clinical context. Apparently, few
researchers have embraced this topic, but hopefully
that will change in the near future. Based on the
current state of knowledge, some key points should be
investigated:
• detection of bacterial aggregates in the root canal/
dental pulp by direct optical methods;
• improvement of protein yield in dentinal fluid
collection;
Table 1: Studies on PMN markers to diagnose the inflammatory status of the pulp or the periapex*
Reference Substrate Target molecule(s) Significant result**
Karapanou et al. 2008 (82) GCF IL-8 yes
Shin et al. 2011 (83) GCF MMP-8 yes
Belmar et al. 2008 (84) GCF MMP-9 yes
Nakanishi et al. 1995 (90) Pulpal blood Elastase, prostaglandin E2 yes
Elsalhy et al. 2013 (91) Pulpal blood IL-8 yes
Zehnder et al. 2011 (99) Dentinal fluid MMP-9 yes
Wahlgren et al. 2002 (110) Periapical fluid MMP-8 yes
Guo et al. 2000 (111) Periapical fluid IL-8 yes
Shimauchi et al. 2001 (112) Periapical fluid IL-8 yes
Alptekin et al. 2005 (113) Periapical fluid Elastase yes
Alptekin et al. 2005 (114) Periapical fluid Elastase, prostaglandin E2 yes
Numbers in parentheses relate to the numbers in the reference list.
Abbrevations: PMN: polymorphonuclear neutrophil granulocyte; GCF: gingival crevicular fluid.
*Only studies on individual human teeth of different clinical states are included (no pooled samples).
**Significant difference at the ≤ 5% level between clinically/histologically healthy and diseased teeth.
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• interference of pulpal blood with the assessment of
target proteins; and
• correlation between PMN markers in dentinal
and/or periapical fluid and clinical outcomes, such
as maintained pulp vitality or healing of periapical
lesions.
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